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I LITERATURE PART     
   
1. INTRODUCTION 
 
Mitochondria are membrane-enclosed organelles that are present in virtually all 
eukaryotic cells, except mature erythrocytes and platelets (Mannella 2008, Neustadt and 
Pieczenik 2008). They produce more than 90% of the energy in the cell and they control 
cell death and survival by participating in apoptosis. Mitochondria are not only 
predominant in the ATP production and important regulators of the apoptosis but they 
are also the main producers of cellular reactive oxygen species (ROS) and they maintain 
biochemical balance inside the cell by controlling e.g. ion balance (Szewczyk and 
Wojtzcak 2002). Hepatocytes are rich in mitochondria and their role in drug 
development is crucial, since many drugs direct their toxicity through the mitochondria 
(Xu et al 2004).  
 
 
2. MITOCHONDRIA: STRUCTURE AND FUNCTION 
 
 
2.1 Structure 
 
Mitochondria are very mobile and plastic organelles. They can fuse with one another, 
and then separate again (Parone et al 2006). In many cells, they form a complex 
reticulum that interacts with other cellular organelles, especially microtubules, 
cytoskeleton and endoplasmic reticulum (Frey and Mannella 2008). This enables the 
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unique orientation and distribution of mitochondria in different types of cells and tissues. 
Some  cells  have  only  single  mitochondria  whereas  others  have  thousands  of  them.  
Mitochondria consist of two membranes: inner and outer membrane and the two 
compartments those membranes separate from each other (Dykens and Will 2007, 
Pereira et al 2009). These are called intermembrane space and the mitochondrial matrix, 
as shown in figure 1 (Frey and Mannella 2000; Szewczyk and Wojtczak 2002).  
 
 
Figure 1. The internal structure of the mitochondrion. In a mitochondrion four distinct 
structures can be found: the inner and outer mitochondrial membranes, the matrix and 
the intermembrane space. The inner mitochondrial matrix forms internal structures 
called cristae. ATP is formed in the inner mitochondrial membrane, where ATP 
synthase particles are located (Frey and Mannella 2000). 
 
2.1.1 Mitochondrial membranes 
 
Both mitochondrial membranes consist of lipid bilayers with variety of integral and 
peripheral proteins that take care of transporting and enzymatic functions (Frey and 
Mannella 2000). The outer mitochondrial membrane is permeable to ions and small 
molecules, due to many copies of the transport proteins called porins (Distelmaier et al. 
2008, Pereira et al 2009). Porins form large aqueous channels through membrane, which 
allow small enough compounds (molecular weight 5000 daltons or less) to pass through 
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the intermembrane space freely (Dykens and Will 2007; Szewczyk and Wojtczak 2002). 
Bigger molecules can enter mitochondria only by active transport through mitochondrial 
membrane transport proteins. Outer membrane also contains enzymes that are needed in 
diverse biochemical actions, such as elongation of fatty acids (Toogood 2008).  
 
The inner mitochondrial membrane is highly specialized and forms invaginations called 
cristae, as seen in figure 1 (Mannella 2008, Pereira et al 2009). The inner mitochondrial 
membrane is the place where most of the vital biochemical functions of the mitochondria 
take place. The cristae greatly increase this area allowing proteins, such as cytochromes, 
to function efficiently (Toogood 2008). Lipid bilayer of the inner mitochondrial 
membrane contains relatively high amount of specialized lipid molecule, cardiolipin. 
This structure resembles the composition of the bacterial membranes, and according to 
endosymbiont hypothesis mitochondria are prokaryotic origin, internalized by eukaryotic 
cells. The structure of the inner mitochondrial membrane makes it impermeable to 
unwanted ions. However, cardiolipin is not unique to mitochondrial membranes; it exists 
also in other membranes in the cell. The concentration of cardiolipin is exceptionally 
high in mitochondrial membranes: this is a mark of highly enclosed matrix of the 
organelle. Inner membrane is associated with the molecular machinery of chemiosmosis 
and it contains the entire respiratory chain and ATP synthase complex (Mannella 2008; 
Szewczyk and Wojtczak 2002). Because of respiratory chain that is coupled with proton 
pumping, there is a high voltage difference across the membrane (Dykens and Will 
2007).  
 
2.1.2 Intermembrane space 
 
Because the outer mitochondrial membrane is highly permeable to small molecules, the 
consistency of intermembrane compartment is same than in the cytosol, as far as low-
molecular-weight compounds (ions, sugars etc) are concerned (Mannella 2008, 
Szewczyk and Wojtczak 2002). Large proteins must have specific signal sequences to be 
addressed to mitochondria. One of the intermembrane space proteins is cytochrome c, an 
important protein that triggers apoptosis if released from the outer part of the inner 
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membrane where it is usually located. On the whole, the volume of intermembrane space 
is small. 
 
2.1.3 The matrix 
 
Mitochondrial matrix is a dense solution containing hundreds of enzymes, metabolites 
and inorganic ions (Mannella 2008, Pereira et al 2009, Szewczyk and Wojtczak 2002). It 
is the place where the major biochemical mitochondrial functions take place (Dykens and 
Will 2007). It is the site of the Kreb’s cycle and it also contains the mitochondrial 
genome and other various enzymes required for the expression of the mitochondrial 
genes.  
 
 
2.2 Function 
 
Depending on the cellular energy requirements, different cells have different amounts of 
mitochondria (Neustadt and Pieczenik 2008). Metabolically most active cells have the 
greatest number of mitochondria, e.g. skeletal muscle cells, various cells in the brain and 
hepatocytes in the liver (Szewczyk and Wojtczak 2002). In addition, depending of the 
type of the cell and its function, the density of the cristae vary a lot, being the greatest in 
the cells which do constant work and need much energy (Szewczyk and Wojtczak 2002). 
E.g. cardiac muscle cells have many highly invaginated mitochondria and a little amount 
of matrix. In the mitochondria of the hepatocytes the area of the inner membrane is five 
times greater than the outer membrane. 
 
Mitochondria are the main source of energy in the cells, and they produce more than 
90% of the ATP needed in the cell (Wojtczak 2008). They are not only crucial for the 
energy production and the metabolic pathways, but they have a central role in cell death 
and survival (Kwong et al 2007). They also contribute to the ion balance inside the cell 
(Denton et al 1980). Infants have specific brown fat tissue where mitochondria produce 
heat by uncoupling the H+ efflux from producing ATP (Kowaltowski 2000). The 
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oxidative phosphorylation and the control of the ion balance as well as the regulation of 
the cell death are discussed in detail below. 
 
2.2.1. Oxidative Phosphorylation 
 
Oxidative phosphorylation consists of two events: the flow of the electrons through 
electron transport chain (ETC) to molecular oxygen and the phosphorylation of the 
ADP by inorganic phosphate to form ATP (Toogood 2008, Szewczyk and Wojtczak 
2002). These processes are located in the matrix and the inner membrane of the 
mitochondria. Despite the fact that, in principle, these two events are independent, they 
are still coupled together: one cannot occur without the other. Energy released from the 
process called Kreb’s cycle in form of reduced NADH or FADH2 is used to form ATP 
in the end of the ETC (Dykens and Will 2007). 
 
Mitochondria have two principal sources of energy: pyruvate and fatty acids (Labbe 
2008). Pyruvates come from sugars (for example glucose) and fatty acids from 
triacylglycerols. They both are converted into acetyl coenzyme A (Acetyl CoA) by 
enzymes located in the mitochondrial matrix as shown in figure 2. Acetyl CoA is taken 
to Kreb’s cycle, which changes acetyl CoA into high-energy electron carriers NADH 
and FADH2. Those are transferred to the inner mitochondrial membrane (Dykens and 
Will 2007). Here they enter the ETC (Szewczyk and Wojtczak 2002). NADH is more 
potent in maintaining electrochemical gradient across the membrane, since it gives its 
electrons  to  complex  I  in  ETC,  whereas  FADH2 gives electrons to complex II (Figure 
3). This way NADH goes through the whole ETC transferring more H+ ions across the 
membrane. Energy released from NADH and FADH2 is used to form ATP via 
electrochemical gradient. Oxygen is needed in the end of the ETC, where it is converted 
into water. It is the final product of this process (Szewczyk and Wojtczak, 2002). In the 
next chapters these processes are discussed in detail. 
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Figure 2. The citric acid cycle, electron transport chain and ATP production in the 
mitochondria. This process produces energy for the cell by converting pyruvate and 
fatty acids to Acetyl CoA and further to NADH. NADH gives it electrons to electron 
transport chain, which moves electrons outside the cell thus generating the 
electrochemical gradient across the membrane. When H+ is  taken  back  to  cell,  it  
produced ATP (Alberts et al 2002). 
 
ETC consists of the membrane-bound respiratory enzyme complexes, seen in figure 3 
(Bellance  et  al  2009).  The  first  one  of  the  complexes,  the  complex  I,  is  a  NADH-
dehydrogenase. This is the largest of the respiratory complexes, and it accepts electrons 
from  NADH  after  it  has  left  the  Kreb’s  cycle  (Dykens  and  Will  2007,  Pereira  et  al  
2009). In this process NADH is oxidated into NAD+. Each NADH gives two electrons 
to complex I. They pass through the Complex I and its iron-sulfur-centers to an electron 
carrier ubiquinone (also called coenzyme Q), which is a carrier between complexes I 
and III (Scheffler 2008). During this process, four H+ are taken out of the mitochondrial 
matrix to the intermembrane space to maintain electrochemical gradient.  
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Figure 3: The electron-transport chain of mitochondria. Electrons from NADH move 
through all the complexes, whereas electrons from FADH2 go straight to the complex II. 
Complexes I, III and IV move H+ through the membrane (Figure from Bellance et al 
2009) 
 
Complex II, a succinate dehydrogenase, is attached to the inner surface of the inner 
mitochondrial membrane (Szewczyk and Wojtczak 2002). It accepts electrons from 
FADH2 converting it to FAD (Pereira et al 2009, Sas et al 2007). After this, ubiquinone, 
the same carrier that takes electrons from the complex I, takes electrons to the complex 
III. Complex II is located between complexes I and III, as shown in figure 3. It does not 
carry H+ across the inner membrane. 
 
Complex III, a ubiquinol-cytochrome c oxidoreductase (also called cytochrome b-c1 
complex), catalyses the electron transfer from ubiquinone to cytochrome c. Cytochrome 
c is a peripheral protein, which is bound to the outer side of the inner mitochondrial 
membrane, and it is a trigger of apoptosis when released from the mitochondrial 
membrane, as discussed in chapter 3: apoptosis and necrosis (Szewczyk and Wojtczak 
2002).  Like  the  complex  I,  the  complex  III  transfers  four  H+ ions across the inner 
membrane. 
 
Complex  IV  is  a  cytochrome  C  oxidase.  It  catalyzes  the  formation  of  water  from  
molecular oxygen. Electrons from reduced cytochrome c are transferred to oxygen, and 
the result is two molecules of water (Szewczyk and Wojtczak 2002). Complex IV 
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transfers  two  H+ ions  across  the  membrane,  the  other  two  H+ ions  are  used  in  the  
formation of water (Sas et al 2007). Oxygen reduction is irreversible: once formed, the 
process cannot go to the reverse way. The formation of water is the force that transfers 
electrons through the whole ETC: the oxidation potential grows during the whole ETC 
being the greatest in the molecular oxygen. 
 
The energy from high-energy electrons released during respiration is used to pump H+ 
ions from the matrix to the intermembrane space. This forms electrochemical potential 
(proton gradient) across the inner mitochondrial membrane: inside is negative, outside 
positive (Szewczyk and Wojtczak 2002). pH inside the matrix is 8. Both electric- and 
pH gradient drive protons back into the matrix from the cytosol. This process is called 
chemiosmotic coupling (Szewczyk and Wojtczak 2002).  The potential energy stored 
into this gradient is used to produce ATP (Distelmaier et al. 2007). ATP synthesis takes 
place in an ATP synthase, the “Complex V” in the electron transport chain (Bellance et 
al  2009).  Despite  the  name and  the  fact  that  it  is  a  part  of  oxidative  phosphorylation,  
complex V is not a part of the respiratory chain (Sas et al 2007). The ATP synthase is 
formed  of  two  distinct  components:  Fo and  F1.  The  Fo portion forms a hydrophilic 
pathway for protons to across the inner mitochondrial membrane. The return of the 
protons to the matrix is coupled to the formation of ATP from ADP and phosphate ions. 
This  happens  by  rotational  catalysis:  the  rotation  of  the  F1-portion driven by proton 
motive force couples this motion to the synthesis of ATP (Szewczyk and Wojtczak 
2002). Formed ATP is taken off from the cell by special carrier proteins. Unlike oxygen 
formation in complex IV, ATP formation is reversible. When needed, ATP is 
hydrolyzed back to ADP and Pi. In this process, protons are pumped back to the cytosol 
and energy is released. 
 
There are specific situations when either oxygen or ADP/Pi is not available. If fuels are 
available for the cell, the rate of the oxygen consumption depends mainly on the supply 
of  the  ADP  and  Pi (Scheffler 2008).  If there is oxygen, but no ADP/Pi, the proton 
gradient over the inner mitochondrial membrane becomes the rate-limiting factor for the 
electron flow and the electron transport across membrane is inhibited (Sas et al 2007; 
Scheffler 2008). This kind of situation is called “the resting state”, or state 4 respiration. 
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Low oxygen intake is characteristic to it (Scheffler 2008). A situation, where there is 
fuel, oxygen and ADP/Pi, and the mitochondria is respirating at the maximum rate, is 
called state 3 respiration. If the proton gradient is lost, the mitochondria is uncoupled: 
the respiratory chain is working, but no ATP is formed (Alberts et al 2002). 
 
2.2.2 Control of the intracellular calcium and ion balance 
 
Mitochondria control ion balance inside the cell (Scheffler 2008). Main focus is in the 
control of intracellular calcium, Ca2+. Ca2+ has important roles in modulating several 
mitochondrial and cellular mechanisms.  Free Ca2+ level inside the cell is 10000 times 
higher than outside of the cell (Denton et al. 1980, Kozaltowski 2000). This Ca2+ 
concentration gradient is controlled by the plasma membrane, endoplasmic reticulum 
(ER) and mitochondria (Kowaltowaki 2000). In the plasma membrane, there are special 
channels that  allow a limited amount of Ca2+ to entry into the cell (Rasmussen 1986). 
Mitochondria, as well as the endoplasmic reticulum, modulate cytosolic Ca2+ by 
buffering: Ca2+ ions can accumulate to the mitochondria down the membrane potential, 
as long as it exists (Kowaltowski 2000, Scheffler et al 2001). The increases in the 
cytoplasmic Ca2+ concentration inside the cell are followed by the energy-requiring 
uptake of Ca2+ to the mitochondria and ER (Carafoli 1984). If the mitochondrial ATP 
production reduces, cellular Ca2+ homeostasis is affected. The road is bidirectional: it is 
not only Ca2+ that affects the function of mitochondria, but mitochondria affect the 
homeostasis of Ca2+ (Scheffler et al 2001). 
 
Mitochondrial Ca2+ has two functions: to regulate the mitochondrial metabolism and 
activities and to work as a sink for excess calcium when plasma membrane is unable to 
maintain Ca2+ homeostasis (Denton et al 1980). For example, some enzymes of the 
Kreb’s cycle are regulated by mitochondrial Ca2+ (e.g. pyruvate dehydrogenase 
phophatase). In addition, Ca2+ has an important role as a secondary messenger (Gunter 
and Pfeiffer 1990, Scheffler et al 2001). The regulation of the intramitochondrial 
calcium is a well controlled process. Excess Ca2+ inside the cell is toxic and may cause 
serious consequences and even lead to cell death (Rasmussen et al 1990). In 
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hepatocytes, disruption of the intracellular Ca2+ regulation  leads  to  the  failure  of  the  
structural molecules inside the cell that maintain the shape of the cell, especially actin 
filaments (Lee 2003). 
 
 
3. APOPTOSIS AND NECROSIS 
 
Apoptosis and necrosis are the two most common mechanisms of the cell death 
(Edinger and Thompson 2004). The dying mechanism of the cell is dependent of the 
context and cause of the cell death and often the cell death can have characters both 
from apoptosis and necrosis (Edinger and Thompson 2004). Apoptosis is a programmed 
cell death, which means that it is an intrinsic mechanism for a suicide of the cell and it 
is regulated by several cellular signalling pathways (Danial and Korsmayer 2004). 
Apoptotic cell death is a clean way for cell to die and usually it does not harm the 
neighbouring cells. In contrast to apoptosis, necrosis is often considered as passive cell 
death, causing inflammation and further tissue damage (Fiers et al 1999). Apoptotic cell 
death needs energy in a form of ATP: in situations that there is no ATP available, the 
cells die by necrosis (Suen et al 2008). These two ways of cell death are discussed in 
detail below. 
 
 
3.1 Apoptosis 
 
Apoptosis is crucial in the tissue development, tissue turnover and protection from 
cancer as it prevents the overgrowth of the tissues and destroys defective cells (Bertrand 
et al 1994, Suen et al 2008). Apoptosis balances cell division and controls the deletion 
of the structures that are no longer needed. In these situations apoptosis is maintaining 
normal functions of the body (Fiers et al 1999). In some cases, apoptosis is triggered by 
drugs or other xenobiotics leading to harmful and/or not intended cell death (Edinger 
and Thompson 2004).  
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During apoptosis, cell undergoes controlled process which leads to controlled 
eradication of the cell (Danial and Korsmeyer 2004). In apoptotic cell death 
biochemical events lead to changes in cell morphology: these include condensation and 
fragmentation  of  the  nucleus,  DNA  cleavage  into  small  parts,  blebbing  of  the  cell  
membrane, cell shrinkage, and packaging of the cell into apoptotic bodies without 
breaking the plasma membrane (Gomez-Lechon et al 2001 and Parone et al. 2006). 
Apoptotic bodies are recognized by phagocytic cells and they are phagocyted. No 
damage to the neighbour cells is occurred and the immune system is not activated (Suen 
et al 2008). 
 
Apoptosis is activated by two routes as shown in figure 5: intrinsic and extrinsic (Suen 
et al 2008). Both pathways induce apoptosis by activating the initiator procaspases 
which in turn activate cascade of caspases (Parone et al 2006). Caspases are proteases 
that are synthesized as inactive precursors and are activated usually by other caspases 
(caspase cascade) (Fiers et al 1999). Caspases also activate some other key proteins in 
the cell; these proteins may cause for example the cleavage of the nuclear lamina or the 
destruction of the DNA through DNA-degrading enzymes (Kwong et al 2007). 
Extrinsic pathway is a death receptor-mediated apoptosis (Sas et al 2007, Suen et al 
2008). It is activated by cell surface receptors which lead to the activation of caspases 
which in turn activate the apoptotic machinery, as seen in figure 5. Insintric pathway is 
regulated by mitochondria. Mitochondria control the release of different pro- and anti-
apoptotic proteins from the intermembrane space. The most important of these proteins 
is cytochrome c. It binds to an adaptor protein called Apoptotic Protease Activating 
Factor 1 (APAF1) in cytosol leading to the activation of the caspase 9. This activates 
the caspases that lead to the destruction of the cell (Suen et al 2008). Other important 
proteins that mitochondria regulate are for example Second Mitochondrial-derived 
Activator of Caspase (SMAC) and Diablo, which together form a SMAC/Diablo-
complex (Wang et al 2008). Cytochrome c, SMAC and Diablo are pro-apoptotic 
proteins that induce apoptosis (Bertrandt et al 1994, Malhi and Gores 2008, Parone et al. 
2006). 
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To maintain the balance between apoptosis and normal cell function there are anti-
apoptotic proteins inside the mitochondria that protect the cell from apoptosis. B-cell 
lymphoma 2 (Bcl-2) is a family of proteins which control the release of the cytochrome 
c and other proteins from the intermembrane space and thereby regulate the activation 
of the procaspases. In this family there are proteins that inhibit apoptosis (Bcl-2, Bcl-xL 
and Mcl-1) and proteins that activate apoptosis (Bax and Bak) (Korsmeyer et al 2000; 
Parone et al 2006). Bax and Bak actively induce the release of cytochrome c from 
mitochondria whereas anti-apoptotic proteins of Bcl-2 family inhibit it. Another 
important family of the apoptosis controlling proteins is called the IAP (inhibitors of 
apoptosis) family (Deveraux and Reed 1999). IAP family members can bind to certain 
procaspases or caspases and prevent their activation. 
 
 
Figure 4: The activation of apoptosis by intrinsic or extrinsic pathway. Intrinsic 
pathway is stress-induced and mitochondria-mediated, and it may be caused for 
example by drugs. The apoptotic stimulus includes the activation of Bcl-2-family and 
opening  of  the  MPTP.  This  causes  the  cytochrome c  release  and  caspase  cascade  that  
leads to apoptosis. The extrinsic pathway is death receptor-induced pathway in which 
the binding of a ligand to its receptor leads to caspase cascade activation and release of 
cytochrome c. This leads to apoptosis ( Sas et al 2007). 
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3.2 Necrosis 
 
Necrosis is the form of cell death which is caused by bioenergetic catastrophe caused by 
the lack of ATP (Edinger and Thompson 2004). Unlike in the apoptotic cell death, in 
necrosis the nucleus is not condensed and fragmented, even if there are some nuclear 
morphology changes detectable (Proskuryakov et al 2003). Necrosis is often thought to 
be caused by factors external to cell or tissue, such as drugs, toxins, trauma or infection. 
For example in heart attack hypoxic heart muscle cells die by necrosis causing even 
larger damage to heart. Cell death is also determined so that smaller injuries usually end 
up to apoptotic death whereas more severe forms of injuries to the cell result in necrosis 
(Gómez-Lechón et al 2001).  
 
Typical for the beginning of the necrotic cell death is the swelling of the cell, digestion 
of the chromatin and disruption of the membranes of the organelles. In the later stage of 
the necrosis the ER is vacuolized, the DNA hydrolyzed and the cell is lysed (Kass and 
Price 2008). The release of the intracellular contents and proinflammatory molecules 
after the cell membrane is ruptured leads to inflammation of the rounding tissue.  
 
 
4. MITOCHONDRIAL MECHANISMS OF HEPATOCYTE 
DYSFUNCTION  
 
 
4.1 Mitochondrial hepatotoxicity  
 
Hepatotoxicity can be caused by a xenobiotic such as a drug molecule itself or by its 
reactive metabolite (Dykens and Will 2007). There is relatively large amount of 
mitochondria in the liver cells. Approximately 75% of the hepatic blood comes straight 
from gastrointestinal-tract and due to this oral drugs go first to the liver after the 
absorption from the gastrointestinal tract (Jaeschke et al 2002). Inside the liver cells, 
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mitochondrial dysfunction may lead to many different types of liver damages, such as 
hepatitis (inflammation, including cytolytic acute hepatitis, cholestatic acute hepatitis 
and mixed acute hepatitis), direct injury, cholestasis (without necrosis or inflammation), 
steatosis (fatty liver), steatohepatitis (with both steatosis and necroinflammation), 
hepatosis, and idiosyncratic injury (Boelsterli and Kim 2006, Jaeschke et al 2002, 
Tafazoli et al 2004). Hepatotoxicity caused by drugs is infrequent and normally detected 
idiosyncratically, so that there is a delay between the physiological reaction and the 
ingestion of the drug (Lee 2003). All the mentioned damages are not caused only 
through mitochondrial dysfunctions, but it is one of most common causes for drug-
induced liver injury (DILI) (Dykens and Will 2007; Labbe et al 2008).  
 
 
4.2 Mitochondrial free radical production, disruption of the 
energy metabolism and triggering of the apoptosis  
 
There are three general functions in the mitochondria that are mainly affected by drugs. 
These three are free radical production (ROS and RNS), disruption of the energy 
metabolism (disruption of both fatty-acid oxidation and energy production) and 
induction of the apoptosis (Lee 2003, Mito Sciences 2009).  
 
As described before, most of the electrons from FADH2 or NADH to the mitochondrial 
respiratory chain move through all the mitochondrial respiratory complexes and finally 
combine with oxygen and protons to form water in the complex IV (Dykens and Will 
2007). Free oxygen radicals, called reactive oxygen species (ROS) may form if for 
example some of the complexes in the mitochondria are inhibited by certain drugs or 
their  metabolites  (O’Brien  et  al  2006).  Small  portion  of  the  electrons  of  the  electron  
transport chain may react directly with oxygen and produce superoxide anion which in 
turn is converted into hydrogen peroxide by mitochondrial enzymes (Neustadt and 
Pieczenik 2008; Pereira et al 2009). In normal physiological state 0.4-4% of the oxygen 
consumed in mitochondria is turned into superoxide radicals. These oxygen radicals are 
detoxified by mitochondrial antioxidant defences which include many different 
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enzymes, nucleic acids, lipids or proteins and finally water is formed and no damage is 
occurred: these are discussed in detail below (Neustadt and Pieczenik, 2008, Wojtczak 
2008). In case that there either are not enough mitochondrial antioxidants or the ROS 
production is too fast, ROS start to accumulate into mitochondria (Labbe et al 2008, 
Turrens 2003). Most of the harmful ROS produced is formed in the complexes I and II 
where NADH and FADH2 give their electrons to the  electron transport chain (Turrens 
2003). When excess and harmful ROS production continues and the mitochondrial 
dysfunction is prolonged, the high amount of ROS may lead to the damage of the 
mitochondrial structures that are vulnerable to free radicals, including lipids, proteins, 
oxidative phosphorylation enzymes and mitochondrial genome (Brookes 2005 Jaeschke 
et al 2001). For example the damage of the proteins of the oxidative phosphorylation 
leads to harmful circle, when electron transport chain is not working which is needed to 
form water, and thus even more ROS is produced (Dykens and Will 2007). 
 
Cells do have some defence mechanisms against oxidative stress (Roma and Pozzi 
2008). Defence mechanism against oxidative stress and inactivation of ROS is 
prevented by metal chelation. In addition, physical defences stabilize biological sites 
such as membranes and form steric interference to prevent ROS reaching the target 
(Kohen and Nyska 2002; Roma and Pozzi 2008; Turrens 2003). Antioxidants are one of 
the most important among various defence system mechanisms (Pieczenik and Neustadt 
2006). They can remove pro-oxidants directly by inactivating them and cells have 
variety of antioxidative compounds that ensure maximum protection for the cell 
organelles and mitochondria (Labbe et al 2008). This antioxidant defence system 
contains two major groups; antioxidant enzymes and low-molecular weight antioxidants 
(LMWA). Antioxidant enzymes include direct-acting enzymes and supporting enzymes, 
whereas LMWA-group contains several compounds that can react directly or indirectly 
with  ROS  and  prevent  their  harmful  effects.  The  result  in  each  case  is  that  ROS  are  
converted into water and made harmless. 
 
Another form of reactive species is reactive nitrogen species (RNS) (Neustadt and 
Pieczenik, 2008). RNS forms when nitric oxide (NO) is freely diffused into 
mitochondria from the cytosol or formed by mitochondrial nitric oxide synthase. NO 
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reacts with superoxide radical and forms peroxynitrite. Some mitochondrial 
components, such as complex I, are more sensitive to RNS than ROS. RNS, as well as 
ROS, can lead to cell death (Jaeschke 2001). 
 
Energy metabolism disruption happens if the ATP production falls below that of the 
ATP demand (Sas et al 2007). Reduced ATP production may be the result of lost proton 
gradient across the inner mitochondrial membrane and is often due to the impaired 
electron transport activity in the ETC (Sas et al 207; Pereira et al 2009). The impairment 
itself can be caused by excessive amount of calcium inside mitochondria or exposure to 
ROS or RNS (Turrens 2003). In addition, impaired ETC activity can occur in response 
to inhibition of any enzyme, transport, or pore activity necessary for oxidative 
phosphorylation.  
 
The problems in the ETC may increase the inner mitochondrial membrane permeability 
which is known as the opening of the mitochondrial permeability transition pore 
(MPTP)  (Sas  et  al  2007).  MPTP  is  located  in  the  contact  sites  of  the  inner  and  outer  
mitochondrial membrane, and it is composed of several proteins forming multiprotein 
complex (Toogood 2008). The opening of the MPTP causes a rapid loss of the proton 
gradient and leakage of the bigger molecules into mitochondria that in normal 
circumstances are outside of the mitochondrial matrix. This leads to the accumulation of 
water and rupture of the outer mitochondrial membrane, which in turn releases the 
proapoptotic proteins into the cytosol, mainly cytochrome c. Opening of the MPTP may 
be triggered by endogenous compounds, extracellular cytokines or drugs (Kowaltowski 
1999).   
 
To investigate the cytotoxicity in the hepatocytes, several different parameters can be 
measured. Glutathione is one of the major antioxidants in the body, and the amount of 
cellular glutathione (GSH) is declined due to the increased amount of ROS or RNS 
(Kowaltowski  1999).  Thus,  both  the  increased  amount  of  ROS  (or  RNS)  the  cellular  
levels of GSH can be measured (Armstrong et al 2002). Energy metabolism disruption 
can be detected by measuring ATP production, mitochondrial membrane potential 
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(problems in ETC) or oxygen consumption. Cytochrome c release and the activation of 
different caspases (caspases 9 or caspases 3) can be measured as a marker of apoptosis.  
 
 
5. HIGH CONTENT SCREENING IN THE INVESTIGATION 
OF MITOCHONDRIAL HEPATOTOXICITY 
 
 
5.1. Development of the High Content Screening methods 
 
Complete toxicological evaluation of even a single drug candidate is complicated, 
expensive and may take several years to perform (O’Brien et al 2008). Drug-induced 
liver injury is one of the most important toxicity mechanism, and among human 
toxicities it has the poorest correlation with the regulatory animal toxicity tests. In 
addition, hepatotoxicity is the most frequent reason for withdrawal of an approved drug 
and the most common reason for black box warnings (Xu et al 2004).  
 
In the past, toxicity has been primarily tested in vivo. The determination of 
hepatotoxicity has accompanied by several whole-animal assays, which require large 
number of animals (Pereira et al 2009). Studies made in the past show that animal 
models do not predict human toxicity adequately (Xu et al 2004). Because of this and 
due to low consistency with standard in vitro cytotoxicity screening assay results, 
human hepatotoxicity has not been very predictable (Dykens and Will 2007; O’Brien et 
al 2006). Cell based assays are increasingly widely used in cytotoxicity screening 
(Lundholt et al. 2003). Over the last few years a major progress has been made to 
develop different in vitro tests to fulfil testing requirements and to reduce the amount of 
animal tests (Lundholt et al 2003). In vitro testing includes use of living systems such as 
cultured animal- or human cells and tissues. Although conventional cytotoxicity assays, 
such as measuring lactate dehydrogenase (LDH) and ATP-levels inside the cells have 
had a good specificity, the sensitivity has been worse (Gomez-Lechon et al 2001). 
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Conventional  cytotoxicity  assays  usually  measure  end-stage  toxicity  (O’Brien  et  al  
2006). However, even severe toxicity is not always lethal. Also, most cytotoxicity 
assays do not include preincubation with drugs for days, even if the in vitro cytotoxicity 
often takes several days to unfold (O’Brien et al 2006). In addition, most assays express 
only one endpoint, even if the toxicity is often caused by multiple mechanisms that need 
to be tested separately by different methods (Gerets et al 2008, Jaeschke et al 2002). 
 
High Content Screening (HCS) is one of the latest  improvements in the automation of 
quantitative epifluorescence microscopy and image analysis (O’Brien et al 2006). It 
includes the application of the multiparameter fluorescent probe technology. In 
principle it is a sophisticated image analysis program equipped with a microscope 
situated in a box (Irwin et al 2007; Thermo Scientific 2010). It is a way to understand 
compound activities in cell based assays where different parameters can be measured 
and observed: the distribution of certain targets in a cell or individual cell or organelle 
morphology (O’Brien et al 2006). High content screening also enables kinetic 
monitoring of multiple biomarkers of processes that cause toxicity using live cells in 
vitro. When comparing to other methods and technologies automated fluorescent 
imaging enables non-invasive, very sensitive and safe detection (Terai and Nagano 
2008). In a HCS assay each well is usually measured multiple times including many 
different drug concentrations, which provides more confidence to the collected data 
(Irwin et al 2007).  
 
Cells used in HCS techniques are usually primary cells or tumor cell cultures. It is also 
possible to use fluorescent-labelled histological slides (Irwin et al 2007). The goal of the 
assay determines if it is more reliable to use live versus fixed, and animal versus human 
cells. For example, compounds tested may cause either cytostatic or cytotoxic effect, 
and the cytostatic effects are primarily seen with dividing cell populations, whereas 
primary cells usually have limited ability to divide (Irwin et al 2007). 
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5.2 Fluorescent probes 
 
Fluorescent probes are molecules that react with specific biological molecules and make 
them visible from their environment (Johnson 1998). Probes cause a change in either 
the fluorescence intensity or excitation/emission wavelength: in general, change in the 
photochemical properties (Terai and Nagano 2008). The changes in the intensity, as 
well as the modulation of the fluorescence signal as a result of the “activation” (e.g. 
permeabilization of mitochondria) and “accumulation” (e.g nuclear translocation) can 
be measured (Terai and Nagano 2008). According to these changes the analysis of the 
results is carried out. Fluorescent probes have been used since 1980’s. Nowadays more 
and more probes with improved properties are available for the biological applications. 
There  are  probes  separately  for  enzymes  and  proteins  as  well  as  for  lipids,  membrane  
potential measurements and ions (Johnson 1998).  
 
As an example in the figure 5 untreated primary rat hepatocytes have been stained with 
mitochondrial membrane potential dye Tetramethyl Rhodamine Methyl Ester (TMRM) 
(20nM) and nuclear dye Hoechst 33342 (0.8 µM). The red labelled structures are 
mitochondria, the blue spots are nuclei. 
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Figure 5: TMRM (20 nM) and Hoechst 33342 (0.8µM) stained, untreated primary rat 
hepatocytes. TMRM is one of the most commonly used mitochondrial dyes and Hoechst 
33342 stains nuclei. This picture taken with Cellomics ArrayScan by using 20x 
objective shows how cells appear under the microscope. 
 
 
5.3 High Content Screening and mitochondria 
 
As discussed earlier, mitochondria are common targets for toxicants due to their central 
role in cell viability: they are sensitive markers of the cell health and stress (O’Brien et 
al 2006). It has been shown that mitochondrial toxicity is one of the most sensitive 
parameters measuring early cytotoxicity, among cell proliferation and nuclear area 
(meaning condensation of the nucleus) (O’Brien et al 2006).  Most of the mitochondrial 
dysfunctions are seen as alterations in mitochondrial membrane potential or as lowered 
activity in the enzymatic oxidoreductases (Pereira et al 2009). The early sign of the cell 
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injury in which mitochondria is trying to adapt is the growth in mitochondrial 
biogenesis and specific mitochondrial enzymes activities (O’Brien et al 2006). HCS 
enables the studying of the mitochondria in many ways. Mitochondrial proteins and 
their significance in different diseases, mitochondrial pathways for cell signalling and 
the structure of the mitochondria are all possible to examine by HCS (O’Brien et al 
2006; Thermo Scientific 2010b). The mechanistically-based analyses allow to study the 
effects to mitochondrial genetics, calcium homeostasis and oxidative phosphorylation 
(Pereira et al 2009). Such assays are sensitive and enormous amount of data can be 
obtained. This information can be used to construct databases to determine if there are 
some mechanistically  different  types  of  mitochondrial  toxicities  that  might  have  some 
common structural motifs. This may eventually lead to the design of new drug 
candidates with lower risk to mitochondria and improving the success rates in the 
development of new drugs (Dykens and Will 2007).  
 
 
6. SUMMARY 
 
Mitochondria are important in measuring early-stage toxicity in the liver cells due to 
their  key  role  in  cell  functions  and  death.  Both  types  of  cell  death,  physiological  cell  
death apoptosis and accidental cell death necrosis, involve two-step process to be 
activated. First, several physiological and pathological stimuli trigger the increase in 
mitochondrial membrane permeability (Sas et al 2007). This releases the proapoptotic 
factors and destroys the electrochemical gradient over the inner mitochondrial 
membrane. Also the MPTP is formed. Secondarily the consequences of the 
mitochondrial dysfunction (lost of the transmembrane potential, uncoupling of the 
respiratory chain, ROS and RNS formation, outflow of Ca2+ and glutathione and release 
of the intermembrane proteins, e.g. cytochrome c) lead to either plasma membrane 
disruption (necrosis) and / or activation of the caspases leading to apoptosis (Brookes 
2005 Jaeschke et al 2001). The rate of these two processes (protease/endonuclease 
activation versus bioenergetic catastrophe) defines whether a cell undergoes apoptosis 
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or necrosis. The fact that these mitochondrial events control cell death in liver as well as 
in other organs has major implications for the development of new drugs. It is obvious 
that methods that more faithfully report mitochondrial toxicity would serve the early 
stages of drug development by filtering out the mitochondrial toxic drugs which would 
further lead to savings in time, money and resources (Dykens and Will 2007).    
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II EXPERIMENTAL PART 
 
 
7. INTRODUCTION 
 
High Content Analysis (HCA) means the process where image acquired from sensitive 
camera equipped high-resolution light microscope (usually a fluorescence microscope) 
is analyzed automatically with appropriate software producing a lot of information (this 
is why the term used is High Content). High content screening (HCS) is based to the 
HCA, combining the integration of the use of fluorescence based reagents, optical 
imaging instrumentation and image analysis software to automatically measure 
physiological processes in the cells. The term “screening” usually means analysis which 
is done using at least 96 well plates and several molecules are tested simultaneously and 
with high speed (Thermo Scientific 2010). The HCS analysis progress is show in figure 
6. 
 
 
Figure 6: How does HCS analysis progress. Four steps in HCS: First (after choosing the 
suitable cells for specific assay) is the sample preparation including cell production and 
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plating, cell treatment, probe exposure and fixation of the cells if needed. The second 
step is to do the image acquisition, meaning defining the input parameters, exposure 
times and channels used. The third step is the image analysis and the fourth, final step 
the data analysis. 
 
Advantages 
Advantages in HCS compared to former analysis techniques are its capability to analyse 
pictures automatically,not manually (Thermo Scientific 2010). Especially in screening 
manual analysis of the pictures would take far too much time. In addition, it is possible 
to scan multiple parameters per cell at the same time using HCS– this is a clear 
advantage when comparing to conventional screening methods. The drug responses are 
not limited to only one cellular object, which causes that the physiological relevance is 
high. Analysis is also possible to be performed on single cell level or sub-cellular level. 
The data obtained can be stored and analyzed again and again. Additional information is 
possible  to  reach  without  performing  the  cell  culture  again  in  the  limits  of  it  
infrastructure (see challenges).   
 
Challenges 
Major challenges in HCS technique are high variability between assays and the huge 
amount of data it is producing, which causes problems to IT infrastructure. The reason 
for high variability is microscopical technique, when differences can be measured from 
single cell -level.  Image analysis and parameter setting is demanding especially in 
cytotoxicity measuring when the appearance of untreated and treated cells can vary a 
lot. In addition, finding a suitable cell model and culture conditions for HCS might be 
challenging. Also HCS instrument is a big investment for organization. 
 
 
8. SPECIFIC AIMS OF THIS STUDY  
 
The major goal of this study is to set up and optimize new HCS methods for early drug 
cytotoxicity screening. The objective was to implement more reliable, sensitive and 
robust methods with higher throughput screening. Because mitochondria play an 
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important role in cytotoxicity, the special focus of the study was in the mitochondrial 
toxicity measurement.  
 
The specific aims of the study were: 
1.  To implement, optimize and compare mitochondrial toxicity HCS assays in live 
cells and fixed cells in two cellular models: HepG2 hepatoma cell line and rat 
primary hepatocytes.   
2.  To compare the results of HCS cytotoxicity assays with conventional cytotoxicity 
assays (ATP and LDH measurements)  
 
 
9.  MATERIALS AND METHODS 
 
 
9.1 Materials and reagents 
 
Chemicals 
Dulbecco’s Modified Eagle Medium (1X) (DMEM, Gibco, Invitrogen #21969-035), 
Fetal Bovine Serum (heat Inactivated; Gibco, Invitrgen #10500-064), Penicillin-
Streptomycin liquid 100X (Gibco, Invitrogen #15140-122), GlutaMAX 200mM (Gibco, 
Invitrogen 35050-038), Sodium Pyruvate MEM (Gibco, Invitrogen S11360-039), 
Trypsin-EDTA (Gibco, Invitrogen #15400-054), Hoechst 33342 (Invitrogen H3570), 
Dulbecco’s phosphate buffered saline (Gibco 14190), Minimum Essential Medium, 
MEM (Gibco, 51200-046) were acquired from Gibco, Invitrogen. Non-essential amino 
acid solution 100x, without L-glutamine (Sigma, M7145-100ML), Staurosporine 
(Sigma S4400), Rotenone (Sigma R8875) and Dimethyl Sulphoxide (DMSO, Sigma, 
D2650) were acquired from Sigma. Tolcapone was from Orion Oyj, Orion Pharma. 
ATP reagent (BioThema 155-050) was acquired from BioThema. LDH cytotoxicity 
assay kit (Roche 11644793001) was acquired from Roche. Tetramethylrhodamine 
methyl ester, perchlorate TMRM (Molecular Probes T668), Mitotracker Red CMXRos 
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(Molecular Probes, M7152) and Alexa Fluor488 goat anti-mouse IgG (H+L) (Molecular 
Probes A11001) were acquired from Invitrogen (Molecular Probes). Mycoalert Assay 
kit (Lonza, LT07-118) was acquired from Lonza. Primary purified Mouse Anti-
Cytochrome c (BD BioScienses 556432), 96-well plates NUNC plastic (BD 167008) 
and poly-d-lysine coated (BD, BDAA356407) were acquired from BD Bioscienses. 
 
9.1.1 Cell Models 
 
In this thesis two cell models were used: human hepatoma cell line HepG2 and primary 
rat hepatocytes. These two were chosen since they are both widely used in drug 
development (Hewitt et al 2007; O’Brien 2008). HepG2-cell line is best characterized 
and most frequently used cell line in drug development (Brandon et al 2006). In general, 
two major bioinformation pathways exist in metabolic processes in liver: phase I and II. 
Cytochrome P450 pathway is the most important (and largest) of phase I enzymes; 
major  enzymes  of  the  phase  II  enzymes  are  sulfotransferase  (SULT),  uridine  
diphosphoglucuronosyl transferase (UGT) and glutathione transferase (GST). HepG2-
cells express many of the phase I and II enzymes: for example nearly all phase II 
enzymes (excluding UGT) exist (Westerink and Schoonen, 2007a). Primary 
hepatocytes, when handled and isolated appropriately, contain a broad complement of 
transport proteins and metabolic enzymes: both phase I and II. However, the expression 
of these enzymes is lower with HeoG2-cells than with primary hepatocytes, which may 
affect to metabolism of tested compounds. Controversially, HepG2-cells are easier and 
cheaper to handle and cultivate than primary rat hepatocytes, but derived from rat, when 
researching human drugs the correlation between human and rat becomes an issue. 
These two cell models were both handled and treated similarly in experiments and the 
results were compared: these are told in detail below. 
 
HepG2 
In this study, Hep G2 cells (obtained from ATCC, passage number before acquiring 
cells unknown) were used as a cellular model system to implement new cytotoxicity 
assays for the drug screening. The cell stocks were stored in liquid N2. They were 
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grown according to ATCC instructions in flat-bottomed culture flasks. Cell cultivations 
and treatments were done in a cell incubator HeraCell (Heraeus, Kendno Laboratory 
Products) and a laminar flow hood (Kojair). Hep G2 cell vials including 10 x 10^6 cells 
/ vial were taken from the liquid nitrogen storage tank and thawed quickly in a water 
bath  at  +37°C (Julabo  EcoTemp TW12)  and  transferred  to  grow in  flasks.  Cells  were  
grown in a cell culture incubator at 37oC and 5% CO2 in humidified atmosphere in 
Dulbecco’s Modified Eagle medium (DMEM) or Minimum Essential Medium (MEM) 
supplemented with 10% heat inactivated FBS, 1% penicillin-streptomycin, 1% 
glutaMAX I and 1% non-essential amino acids mixture. In addition, MEM was 
supplemented with 1% Sodium Pyruvate MEM.  
 
Used solutions were prewarmed to +37oC  in  water  bath.  Cells  were  treated  gently  to  
avoid causing any harm to them (e.g. breaking the cell membrane). It was paid attention 
that during subculturing or other treatments the cells were not let to dry or be too long 
time in a washing buffer.  
 
Subculturing procedure 
New cultivations were started in 25cm2 flasks to help cells to reach appropriate 
confluence. After the cells had reached the confluence of ~80%, they were transferred 
into 75cm2 flasks. Old medium was removed and cells were rinsed twice with 
Dulbecco’s  phosphate  buffered  saline  (á  15ml).  To  detach  the  cells  trypsin-EDTA  (5  
ml) was added and the cells were kept in the incubator for 2 minutes or more if needed. 
The detachment of the cells was assured under microscope. Adherent HepG2- cells 
looked longish in poly-d-lysine coated -flasks and detached ones were round shape. In 
NUNC plastic non-coated flasks the difference was not that obvious, cells were round 
shape both when attached and detached. Extra attention was paid to those cells to make 
sure they had detached properly. Trypsin was inactivated using culture media, either 
DMEM or MEM, by adding 5ml of the medium to culture flasks. Cells were pipetted 
back and forth to dislodge and break the cell clumps.  Cells were transferred into new 
75cm2 culture flasks, in ratio 1:2 or 1:5, depending on the purpose when they were 
needed for the next time. ATCC recommends subcultivation ratio to be 1:4-1:6 and the 
medium renewal twice a week. In these experiments, cells the following ratios were 
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used: 1:2 one day before 80% confluence, and 1:5 three or four days before 80% 
confluence. Cells, which were trypsinized and transferred to new flask, formed a new 
passage which was marked using P-letter (P4, P5 or P6 etc).  The highest passage 
number used in this study was P15, because cells were not passaged more than 10 times 
after thawing. 
 
Optimization of culture plates, cell confluence and medium used 
In order to plate the cells to 96-well plates, the cell count was performed by cell counter 
(Bûrger). Normally, the volume of media in each well was 100µl, and the desired cell 
density  was  optimized  for  each  treatment  as  discussed  in  the  following.  After  seeding  
the cells to 96-well-plates, the cells were observed under a phase contrast microscope on 
daily basis for 4 days. Photos were taken each day using Olympus Ix50.  The fresh 
media was changed after two days of plating according to ATCC recommendations. 
Flasks had filter caps for good gas exchange. 
 
Mycoplasma test  
HepG2-cells were tested for mycoplasmas with Mycoalert Assay kit (Lonza, LT07-
118). MycoAlert reagent and Mycoalert Substrate were prepared according to 
manufacturer’s instructions. Reagent vial was mixed and let to equilibrate for 15 
minutes at room temperature. MycoAlert assay Control set was used as a negative and 
positive control. One ml of MycoAlert Assay Buffer was added into the vial containing 
the lyophilized MycoAlert Assay Control (positive control). MycoAlert Assay buffer 
was used as negative control. 
 
For mycoplasma testing 2 millilitres of cell culture supernatant was centrifuged at 740G 
(1500RPM) for 5 minutes. 100µl of cleared supernatant was transferred to luminescence 
compatible plate. 100µl of MycoAlert Reagent was added to each sample and incubated 
for 5 min before the first luminometric measurement. 100µl of MycoAlert substrate was 
added to each sample and after 10 minutes the second measurement was performed 
followed by the calculation of ratio: 
2
1
tMeasuremen
tMeasuremen  
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Primary rat hepatocytes 
Male HanTac: WH-rats (Taconic M&B, Ry, Denmark), weight about 300g, age about 7 
weeks were used to isolate fresh hepatocytes by in situ collagenase perfusion (Seglen P, 
1976). Rats were anesthetized with Mebunat (60 mg/ml) 70 mg/kg prior to undergoing 
liver perfusion. All animals used were handled in accordance with the principle of  
Animal Ethics committee of the state Provincial Office of Southern Finland, 
Hämeenlinna –approved animal protocol for hepatocyte perfusion. 
 
Primary rat hepatocytes were seeded to commercially collagen-coated 96 well plates, 
30000 cells to each well. Desired viability was above 80% and it was determined using 
cell counter (Byrger). William’s E medium supplemented with 10% FCS, 2mM 
glutamine, 10mM Hepes, 50 µg/ml gentamycin, 1µM insulin, 40ng/ml dexamethasone 
and 2.5 µg/ml amfoterisine was used as a culture medium. After 2 hours of seeding, 
cells were washed with pre-warmed 37oC PBS 100µl/well to remove dead cells from the 
wells. Dead cells cause autofluorescence with certain probes and will be discussed in 
more  detail  later.   After  washing  with  PBS,  medium  was  changed  to  serum  free  
medium. Cells were washed with pre-warmed PBS again just before experiments.  
 
9.1.2 Probes 
 
Four different fluorescence probes were used in these studies: Hoechst 33342, 
tetramethylrhodaminemethylester (TMRM), Mitotracker Red CMXRos and cytochrome 
c primary antibody together with Alexa 488 conjugated secondary antibody. Of these 
four probes, Hoechst 33342 and TMRM were used together in live cell method, whereas 
Hoechst 33342, Mitotracker Red CMXRos and cytochrome c antibody together with 
Alexa 488 conjugated secondary antibody were used in fixed cell method. In order to 
avoid mitochondrial toxicity and potential artefacts caused by fluorophores, the 
concentrations of the dyes were kept as low as possible. 
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Hoechst 33342 
Hoechst 33342 is a bisbenzimide dye which is cell membrane-permeant and and binds 
to minor groove of DNA. It is widely used for staining the nuclei of living cells in many 
cellular applications, including cell-cycle and apoptosis studies (Invitrogen 2010). As 
described in the literature part of this thesis, the characteristic breakdown of the nucleus 
during apoptosis comprises collapse and fragmentation of the chromatin, degradation of 
the nuclear envelope and nuclear blebbing. Hoechst 33342 is lipophilic and therefore it 
is readily taken up by intact cells or during the initial stages of apoptosis, which is an 
advantage in this experiment when comparing to other nucleus stains. In addition 
Hoechst 33342 can be excited by the most conventional fluorescence excitation sources 
and it exhibits relatively large Stoke shifts, thus making it suitable for multicolour 
labelling techniques.  Hoechst 33342 excitation / emission maxims are 350 / 460nm. It 
fluorescents bright blue / cyan -colour upon binding to DNA.  
 
Tetramethylrhodamine methyl ester, TMRM 
TMRM is a potentiometric, mitochondria-selective stain, which is accumulated to live 
mitochondria driven by membrane potential (Ehrenberg et al 1988). It is rapidly and 
reversibly taken up by healthy, live cells. It is non-toxic and highly fluorescent. During 
cell death, active mitochondria are disrupted. Disruption includes changes in membrane 
potential and alterations to the oxidation-reduction potential of the mitochondria due to 
the opening of the mitochondrial permeability transition pore (MPTP). The opening of 
MPTP allows small molecules and ions to pass through the mitochondrial membrane. 
The result is decoupling of the respiratory chain and the release of cytochrome c into the 
cytosol as well as the loss of membrane potential, which leads to cell death. Due to all 
these changes during apoptosis, TMRM is not working in dead cells and the reduced 
intensity of TMRM fluorescence in the cells is a marker of apoptosis. In this study, two 
parameters were measured. The reduced membrane potential is seen as a reduced 
intensity of fluorescence of TMRM. The second parameter measured was the area of 
mitochondria, which is, as well as the intensity of fluorescence, smaller in apoptotic 
cells. When these parameters are compared to those parameters of the healthy cells, the 
apoptotic status of cells can be predicted. The excitation and emission maxims of 
TMRM are 548nm and 573nm, respectively. 
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MitoTracker Red CMXRos 
Mitotracker Red CMXRos is cationic, lipophilic cell-permeant probe, which contains a 
midly-reactive chloromethyl moiety for labelling mitochondria (Gilmore et al 1999). 
When cells are incubated with this probe, it passively diffuses across the plasma 
membrane and accumulates in active mitochondria upon membrane potential: cationic 
fluorophore accumulates into the negatively charged mitochondrial matrix. It is also 
retained in the mitochondria after fixation of the cells, due to the chloromethyl group 
which binds to mitochondrial proteins. Its emission / excitation maxims are 578 / 599 
nm. In this study, MitoTracker Red CMXRos staining was aimed to be used to study the 
colocalization of mitochondria and the cytochrome c between healthy and damaged 
cells. However, the method to be used required optimization, that was beyond the time 
limit of this thesis. Therefore, the results of this staining are not shown. 
 
Cytochrome c antibody and Alexa 488 conjugated secondary antibody 
Rat cytochrome c-antibody was used as a primary antibody. It is a monoclonal antibody, 
which is produced in mouse cells. In these cells, rat cytochrome c has been used as an 
antigen. Alexa 488 conjugated anti-mouse IgG was used as a secondary antibody. (Bd 
Bioscienses 2010).  
 
Cytochrome C is  a  water-soluble  protein  which  either  promotes  cell  survival  or  death  
depending upon its intracellular location (more details, see literature part, chapter 3.1 
Apoptosis and necrosis). Proapoptotic stimulus releases cytochrome c to cytosol, where 
it activates caspases that lead to apoptotic cell death. Cytochrome c-antibody recognizes 
the cytochrome c and binds to it. Alexa 488 conjugated to goat anti-mouse IgG (H+L) 
secondary antibody was used as fluorophore to detect cytochrome c localization. Alexa 
488 emission / excitation maxims are 495/519 nm. 
 
Table 1: Cellomics ArrayScan filters and wavelengths. The four probes used in 
experiments and the wavelengths for excitation / emission and the Cellomics ArrayScan 
filters used. 
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9.1.3 Model substances 
 
In  this  study  three  different  substances  known to  be  toxic  to  mitochondria  were  used:  
staurosporine, rotenone and tolcapone. Staurosporine, rotenone and tolcapone 
concentrations, 7 concentrations each (0.078, 0.016, 0.3125, 0.625, 1.25, 2.5, 5.0 and 
10.0µM staurosporine, 0.078, 0.016, 0.3125, 0.625, 1.25, 2.5, 5.0 and 10.0µM rotenone 
and 0.78, 0.16, 3.125, 6.25, 12.5, 25, 50 and 100µM tolcapone) were chosen according 
to literature and optimized so that the toxicity is seen with chosen concentrations 
(Tafazoli et al 2004; Feng and Kaplowitz 2002). The sedimentation of the drug 
compounds with previously mentioned concentrations was done using nephelometer. 
No sedimentation was found using these concentrations. 
 
 Hoechst 33342 TMRM Mitotracker 
Red CMXRos 
Cytochrome c 
ab + Alexa488 
conj. sec ab 
Parameter Cell count, nucleus 
area and intensity 
Mitochondria 
intensity and area 
Localization of 
mitochondria 
(Colocalization 
with Cytochrome 
c) 
Localization of 
cytochrome c in 
cells 
(Colocalization 
with 
mitochondria) 
 
Emission/ 
Excitation 
350/460 nm 548/573 578/599nm 495/519nm 
Filter used 
in 
Cellomics 
ArrayScan 
XF93 Hoechst 
33342,  
XF93 TRITC XF93 TRITC XF93 FITC 
Excitation 
filter wave- 
lenghts 
365±25 nm - 
515±10 nm 
549±4 nm - 
600±13 nm 
549±4 nm - 
600±13 nm 
475±20 nm - 
515±10 nm 
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Staurosporine 
Staurosporine is a microbial alkaloid broad spectrum inhibitor of protein kinases, 
especially protein kinase C (PKC) and has been shown to induce apoptosis through 
mitochondria-mediated cell death signalling (Fallon 1990, Wang et al 2008). 
Staurosporine induces mitochondria dysfunction figured as cytochrome c release and 
bid cleavage, but it also induces both caspase-8 and caspase-9 cleavages (the role of bid 
is discussed in detail in section 3: Apoptosis and necrosis). These two, caspase-8 and 
caspase-9, are caspases which can induce apoptosis (see literature part). 
 
Rotenone 
Rotenone is a naturally occurring botanical compound obtained from the roots of Derris 
sp. It is an inhibitor of mitochondrial electron transport, specifically inhibiting NAD-
linked substrate oxidation by mitochondria at the oxygen side of NADH dehydrogenase 
(complex I). This increases the formation of ubisemiquinone, the primary electron 
donor in mitochondrial superoxide generation and leads to formation of reactive oxygen 
species (ROS) and decreased formation of ATP. As told in the literature part of this 
thesis, the extend formation of ROS may lead to apoptosis. With rotenone, apoptosis is 
closely linked to formation of ROS (Li et al. 2003). The reaction is dose-dependent. 
 
Tolcapone 
Tolcapone is a catechol-O-methyl (COMT) transferase inhibitor which was indicated to 
treat Parkinson’s disease but was withdrawed from market soon after (Tafazoli et al 
2005). Nowadays it is back on the market with black box warnings (Dykens and Will 
2007). The exact mechanism of toxicity remains obscure, but it has been suggested that 
mitochondrial uncoupling of oxidative phosphorylation may be involved in cytotoxicity 
and hepatotoxicity (Haasio et al. 2002). In the liver, tolcapone is metabolized to amine 
and acetylamine (Smith et al 2003). These metabolites are supposed to form reactive 
species and cause oxidative stress, which leads to GSH oxidation and lipid peroxidation.  
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9.2 Optimization of live cell method 
 
The following steps in optimizing live cell method were done only for HepG2-cells. In 
order to optimize the cell density for the experiments, three replicates of 2000, 4000, 
5000, 8000, 10000, 16000, 20000 and 40000 cells/well were plated to 96-well plates.  
Two different materials were tested: non-coated plastic or poly-d-lysine coated 96-well 
plates.  The  confluence,  as  well  as  growth  and  overall  condition  of  the  cells,  were  
observed daily for four days using phase contrast microscope.  
 
Cells were let to attach and recover for either 20 hours (HepG2) or 24 hours (primary rat 
hepatocytes) in a cell incubator (37oC,  5%  CO2). To find optimal test compound 
concentrations cells were treated with 0.078-10µM staurosporine, 0.078-10µM rotenone 
and 0.78-100µM tolcapone or vehicle only (0.5% DMSO)  and incubated at +37°C, 5% 
CO2 for either 2,  6 or 24 hours.  As a control there were also non-treated cells without 
DMSO. 
 
After treatments, cells were loaded with Hoechst 33342 and TMRM at concentrations of 
0.2, 0.4, 0.8 or 1.6 µM of Hoechst 33342 and 5 / 10 / 20 / 40 nM TMRM for 1 h. After 
incubation, the cells were observed using Cellomics ArrayScan. Different exposure 
times were used depending on the probe concentration, and according to the results the 
optimum dye concentrations were chosen. This was done separately to both cell types, 
for HepG2 and primary rat hepatocytes. 
 
 
9.3 Optimization of fixed cell method 
 
For optimization of fixed cell method the cells were treated similarly as described 
above. For probe concentration testing cells were stained with 50 / 75 / 100 / 150 / 200 
nm of Mitotracker Red CMXRos. Hoechst 33342 concentration was 0.8µM that was 
was optimized in live cell method. Cells were observed using Cellomics ArrayScan and 
after this cells were fixed.  
35 
 
 
Pre-warmed 3.7% formaldehyde solution was used for fixation of the cells. Pre-
warming ìs crucial to maintain cell integrity. Cells were incubated with fixation solution 
in dark chamber at 37oC  (not  in  a  CO2- incubator) for 15 minutes. This was the 
recommendation of manufacturer (invitrogen). Cells were washed twice with PBS á 
100µl. Permeabilization was done using 0.2% triton X-100 solution, which was 
incubated with the cells at room temperature for 10 minutes. Cells were washed once 
with PBS before proceeding to immunocytochemistry protocol.  
 
In immunocytochemistry protocol cells were first washed with 100µl/well of PBS. PBS 
was then aspirated and cells were incubated in blocking buffer (10% FBS in PBS) at 
room temperature for 15 minutes. After this cells were incubated with primary antibody 
solution (antibody diluted in 1:150, 1:300 or 1:450 in PBS with 10% FCS and 0.2% 
triton-X 100) for 2 hours in dark chamber in +37oC. After incubation with primary 
antibody solution cells were washed three times for 5 minutes with wash buffer. 
Secondary antibody / staining solution (antibody diluted in 1:150, 1:300 or 1:450 in 
PBS with 10% FCS and 0.2% triton-X 100) was added, and cells were incubated at 
room temperature for 45 minutes. Cells were washed twice with wash buffer and finally 
wash buffer was replaced with PBS. Cells were evaluated with Cellomics ArrayScan. 
 
To study if there were any photo bleaching or other changes happening during 
immunocytochemistry staining cells were treated as normal and scanned after each step 
when doing an immunocytochemistry protocol. The cells were stained with either of the 
four following ways:  
 
1: 0.8µM Hoechst 33342  
2: 0.8µM Hoechst 33342 + 100nm Mitotracker Red CMXRos 
3: 0,8µM Hoechst 33342 + 1:300 cytochrome c antibody and 1: 300 Alexa 488 
conjugated secondary antibody or  
4: 0.8µM Hoechst 33342 + 100nm Mitotracker Red CMXRos + 1:300 cytochrome c 
antibody and 1: 300 Alexa 488 conjugated secondary antibody.  
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Cells were scanned in many stages: after Mitotracker Red CMXRos staining (=before 
fixation), between fixation and permeabilization, after permeabilization before 
immunocytochemistry, and also after blocking, before adding primary antibody to the 
cells. This was done to see how the signal is changing during protocol and also to see if 
there is leaking between different channels. 
 
 
9.4 Cellomics ArrayScan VTI HCS Reader settings, 
bioapplications and specific parameters of the cell imaging 
measurements 
 
Cellomics ArrayScan VTI HCS Reader is an automated epifluorescent Zeiss 
microscope developed for HCS. It is situated in a box and image analysis software is 
added to the computer that receives the images from microscope. Excitation source is a 
mercury-xenon lamp which has a broad excitation spectrum. Lamp can be easily 
changed when the excitation power is getting lower. Cellomics ArrayScan used in this 
study has three different objectives: 10x, 20x and 40x and automated focusing. 
Workstation can be equipped with plate handler. Six channels exist in Cellomics 
ArrayScan. All the channels are possible to use with different bioapplications, 
depending on the amount of probes and the aim of the study. Each channel is possible to 
equip with different filter that define certain excitation/emission wavelengths for each 
channel.  This  enables  the  use  of  different  probes  that  need  different  wavelengths  for  
excitation and emission. Channels and filters used in these experiments are told in table 
1. 
 
Bioapplications are software that indicate which input parameters must be defined to 
obtain certain output parameters and results from scans. They provide information of 
the biological properties of the cells. Different parameters can be measured by different 
bioapplications). Bioapplications used in this thesis, Cell Health Profiling and 
Compartmental Analysis, are examples of the bioapplications that provide general 
information of the cell. There is also bioapplications that report more specific features 
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of the cells available: total amount of different bioapplications is 18 at the moment. 
Data obtained by using each bioapplication can be from individual cell level to a 
subpopulation of cells or to the whole population of the cells in a well. Data of each cell 
includes size, shape, the amount of fluorescent label (meaning intensity) and pattern of 
fluorescence. 
 
Cell Health Profiling -Bioapplication 
Cell Health Profiling protocol was used in live cell analysis. This bioapplication is used 
to measure different cell health indicators (mitochondrial transmembrane potential, 
nucleus morphology and size) from both nucleus area and cytoplasm (circ and ring, will 
be discussed in detail later). The primary object is defined at channel 1 (Hoechst 33342-
stained nuclei) and the measurement regions at other possible channels 2-6 is derived 
from this. In this experiment only channel 2 was used to measure mitochondrial 
transmembrane potential using staining of the cells with TMRM. 
 
Compartmental Analysis -Bioapplication 
Compartmental Analysis -bioapplication was used for fixed cells. Compartmental 
Analysis is used to determine the movements of macromolecules in or between 
particular cellular regions, compartments or organelles (Thermo Scientific 2010).  
Compartmental Analysis is a High Content Screening bioapplication which allows the 
simultaneous quantitation of different macromolecules between four different cellular 
regions: cellular circ, cellular ring, circ spots and ring spots, as seen in Figure 7. To do 
this, the application measures the intensity from a primary cellular object in channel 1 
(Nucleus)  and  after  this  the  intensity  from  distinct  regions  of  the  cell,  as  well  as  the  
intensity  ratios  and  differences  from  the  different  regions.  In  cells  which  are  stained  
with cytochrome c antibody and Alexa 488 conjugated secondary antibody, the 
movement of cytochrome c from mitochondria to nucleus after apoptosis can be 
detected using Compartmental Analysis -bioapplication. The intensity of Alexa 488 in 
nucleus (circ spots) is compared to the intensity of Alexa 488 in cytoplasm (ring spots) 
to see the difference. This difference or ratio should be increasing in apoptotic cells, 
when some of cytochrome c is leaking from mitochondria and moving to cytosol and 
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nucleus. The intensity of Alexa 488 in nucleus is also measured. This value should also 
increase in apoptotic cells. 
 
Figure 7: Parameters that can be measured with compartmental analysis-bioapplication. 
These include parameters that define spots from either ring or circ region and the 
average or total intensity of both these regions. (Thermo Scientific 2010). 
 
9.4.1 Input parameters 
 
In Cellomics ArrayScan bioapplications there are different types of input parameters:  
1. Object Identification methods 
2. General Assay Parameters 
3. Channel-specific assay parameters 
4. Basic assay parameters 
5. Object selection parameters  
 
These parameters are used for the object identification and for specifying the scanning 
parameters. The detailed explanations of the parameters and how they affect to the 
image acquired can be found in Cellomics ArrayScan bioapplication manuals. Short 
overviews of the most critical parameters are explained in the Chapter 10.4.1: Input 
Parameters.  
39 
 
 
9.4.2 Output parameters 
 
Output parameters are the actual results of the scans in numeric form. Output 
parameters are specific for each bioapplication used, and thus are not discussed here in 
detail. All available parameters for Cell Health Profiling bioapplication and 
Compartmental Analysis bioapplication can be found in the manuals of these 
bioapplications (Thermo Scientific 2010). Optimization of selected output parameters 
for these assays is explained in the Chapter 10.4.2: Cellomics results and Output 
parameters. 
 
 
9.5 Conventional analysis of cytotoxicity  
 
Cells were grown the same way than in live cell method. DMSO concentration in 
treatments was 0.5 %, which was the concentration used in reference wells for negative 
control. As a positive control cells were treated with 0.2% digitonin. Digitonin is a cell 
membrane-perturbing detergent causing cell death. After incubation the media were 
pipetted to clear 96 well plates and stored in -80oC for LDH assay. Trichloroacetic acid 
(TCA) was added to the cells, and the cell plates were stored in -80oC for ATP assay. 
 
9.5.1 ATP assay 
 
Adenosine triphosphate, ATP, is crucial for cells. The amount of ATP is decreased 
during apoptosis. Cells in TCA were let to melt at room temperature for at least 1 hour. 
Plates were centrifuged 260G (2500RPM) for 10 minutes at room temperature (22oC). 
10 µl of each sample was added to a well of a white 96 well plate. 90µl of neutralizing 
buffer (Tris-EDTA-buffer) was added and pH of the sample was measured. 25µl of 
ATP reagent was dispensed by a dispenser to each well. ATP reagent used was firefly-
luciferin reagent with a stable light emission, with a decay rate of 0.9% in minute. 
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When reagent is added among sample, firefly luciferase reaction takes place. Reaction is 
as following:  
LIGHTCOinoxyluciferPPAMPOluciferinDATP i
luciferase ??????? ????? 22  
In this reaction, the consumption of ATP is low and luciferase activity remains 
unchanged during measurement. This allows cellular release of ATP to be monitored 
during the measurement. Measurement was done using Fluoroscan Ascsw26. (Biothema 
2010) 
 
9.5.2 LDH assay 
 
Lactate dehydrogenase, LDH, is a stable cytoplasmic enzyme found in all cells. After 
cell membrane damage, LDH is released from cells to cell culture and can be measured. 
As described above, 96 well plate cell-free culture media were stored at -80oC. They 
were let to melt at room temperature for 1 to 1.5 hours. Media were centrifuged 10 
minutes 250g at room temperature (+22oC). 20 µl of each supernatant was transferred to 
a  clear,  flat-bottom  96-well  plate.  30  µl  of  PBS  was  added  to  each  well.  Plates  were  
shaken for about two minutes. 50µl of LDH-reagent (includes pyruvic acid, NADH and 
phosphate buffer) was added to each well and plates were incubated 20 minutes in dark 
at room temperature. During incubation LDH-reaction mixture reacts with sample in 
two steps. First NAD+ is reduced to NADH/H+ by the LDH-catalyzed conversion from 
lactate to puryvate. Second, the catalyst transfers H/H+ from NADH/H+ to the 
tetrazolium salt  INT which  is  reduced  to  red  coloured  formazan.  The  intensity  of  this  
colour was measured with Labsystems iEMS Reader. The higher the amount of LDH, 
the more formazan is formed and the more intense the red colour. Formazan dye formed 
has an absorption maximum at 500nm, where tetrazolium salt INT shows no absorption 
(Roche 2010). 
 
 
9.6 Evaluation of phototoxicity 
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Phototoxicity means toxic effects caused by the excitation of the probes in the cells and 
it  may  cause  the  errors  to  the  results  particularly  when  measuring  cytotoxicity  by  
fluorescent probe based methods. Phototoxicity is often dependent of the probe used 
and it is thought to be the result of the non-radiative energy transfer during the 
excitation of the probe. This may form free oxygen radicals. For this reason the 
exposure time when scanning cells with Cellomics ArrayScan should be as short as 
possible. 
 
To see if there was significant phototoxicity in these experiments cells were first 
distributed to 96 well plates. They were let to attach over night, about 20-24 hours. 
Cells were stained with 0.2 / 0.4 / 0.8 / 1.6 µM Hoechst 33342 and 5 / 10 / 20 / 40 nM 
TMRM. There were two plates, and only the other one was exposured using Cellomics 
ArrayScan. ATP was measured from both plates, and results were compared to see if 
there is difference between exposured and non exposured cells.  
 
 
10. RESULTS 
 
 
10.1 Optimization of cell culture conditions 
 
HepG2 
The optimization  of  cell  culture  conditions  of  HepG2 cells  was  done  in  many phases.  
The amount and confluence of the cells in the wells of a 96-well plate were optimized, 
and the influence of plate- and flask materials and coating, as well as different media 
and  their  amount  was  studied.   In  the  end  of  each  optimization  stage  the  cells  were  
stained using nucleus dye Hoechst 33342 and the plates were scanned using Cellomics 
ArrayScan. The optimal cell culture settings were determined based on Cellomics 
ArrayScan scan results and how the cells looked like under a normal phase microscope. 
Particularly the confluence and the shape of cells were evaluated, since they both are 
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critical factors for successful image analysis and also indicate well-being of the cells. 
The aim was to reach a state were the cells grow in a monolayer around 80 % confluent 
at the time of scanning and they are big enough so that the nucleus and cytosol could be 
easily identified and measured in image analysis. 
 
Cell amounts tested vary from 2000 cells to 40000 cells in each well. The growth of the 
cells was observed during several days. When scanned using Cellomics ArrayScan, the 
optimal cell density was around 10000 cells in each well when the experiment was done 
on the next day, and thus this was the amount of cells decided to use in these 
experiments. If less than 10000 cells were subcultured in a well, the confluence was too 
low, whereas more than 10000 cells / well caused cells to be close to each other and the 
cells and nuclei could not be separated using Cellomics ArrayScan image analysis tools.   
 
Two different culture media for HepG2 cells were used and compared in this study: 
DMEM and MEM, one plate with DMEM and the other with MEM. Biggest difference 
between  these  two  mediums  is  the  amount  of  glucose  (DMEM:  4500mg/l,  MEM:  
1000mg/l ) and the lack of phenol red in MEM. In both mediums, glutamax I contains a 
necessary amino acid L-glutamine in the stabilized form as dipeptide L-Alanyl-L-
Glutamine.  This  is  an  essential  component  of  most  cell  culture  media  and  serves  as  a  
source of energy. Non-essential amino acids stimulate growth and prolong the viability 
of the cells. In MEM, where there is no that much glucose, sodium pyruvate was used as 
a source of carbohydrates. Different media were tested because the medium may have 
an effect to the growth of the cells and behaviour in cytotoxicity tests, and the phenol 
red in DMEM may cause some autofluorescence in Cellomics ArrayScan scans. Cells 
were observed daily during four days and the differences in cell growth were followed. 
No major differences were seen between the two media. In MEM, cells grew just a little 
faster  than  in  DMEM. In  addition  because  there  was  a  concern  that  the  phenol  red  in  
DMEM could cause some autofluorescence in Cellomics ArrayScan scans the MEM 
was decided to use. The images of the HepG2 cells grown in DMEM and MEM media 
are shown in figure 8. 
 
43 
 
 
Figure 8: The effect of medium for the growth of HepG2 cells: On the left is DMEM, 
MEM is on the right. Cell density 10000 cells / well, pictures have been taking one day 
after cultivation with a phase contrast microscope equipped with camera using 10x 
objective. 
 
The amount of the medium was also tested, since it may have an effect to the growth 
and  distribution  of  cells  especially  in  96-well  plates.  To  study  this,  HepG2 cells  were  
grown in 100ul or 200ul of medium / well of a 96-well plate for four days and the 
differences were observed microscopically. No differences were seen in cell growth 
between different amounts of medium. The smaller amount (100 µl) of medium / well 
was decided to use, since less media, probes and particularly new drug candidate 
molecules are consumed this way. 
 
To  study  the  effect  of  plating  material  on  HepG2 growth  the  cells  were  cultivated  on  
plastic (NUNC, BD Bioscienses 167008) and poly-d-lysine coated (BD Bioscienses, 
BDAA356407) flasks and 96-well plates. HepG2 cells grew better in poly-d-lysine 
coated material than in NUNC plastic plates and flasks: the cells grew faster and they 
were distributed more evenly in the wells with poly-d-lysine coating. In NUNC plastic 
flasks and plates the cells grew in clumps and the identification of individual cells by 
Cellomics ArrayScan image analysis tools was difficult or impossible.  Therefore, poly-
d-lysine coated culture vessels were decided to use for HepG2 cells. The images of 
HepG2 cells cultivated on two different plating materials are shown in Figure 9 
(pictures from phase contrast microscope) and 10 (pictures from Cellomics ArrayScan). 
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Figure 9: The effect of plating material on the growth of HepG2 cells. NUNC 
plastic plate is on the left, poly-d-lysine coated plate on the right. Pictures are taken 
under a phase contrast microscope using 20x objective one day after plating of the cells 
(10000 cells / well).  
 
 
Figure 10: The effect of plating material on the growth of HepG2 cells. NUNC 
plastic plate is on the left and poly-d-lysine coated plate is on the right. Cells are stained 
with 0.8µM Hoechst 33342 and pictures are taken using Cellomics ArrayScan 20x 
objective one day after plating of the cells (10000 cells / well).  
 
 
Mycoplasma testing 
To study that HepG2 cells are not infected by mycoplasmas they were tested using 
Mycoalert assay. Mycoplasmas are the smallest and simplest prokaryotes, and they are 
dependent on their hosts for many nutrients due their limited biosynthetic capabilities. 
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Mycoalert Assay - test is selective biochemical test that exploits the activity of certain 
mycoplasma enzymes. The viable mycoplasma are lysed and the enzymes react with the 
MycoAlert  substrate  catalyzing  the  conversion  of  ADP  to  ATP.  When  this  ratio  is  
measured before and after addition of MycoAlert substrate, the indicative absence of 
mycoplasma in the sample can be determined. If there are no mycoplasma enzymes in 
the sample, the second measurement after MycoAlert substrate shows no increase over 
the first. The presence of mycoplasma increases the amount of ATP remarkably. The 
following bioluminescence reaction takes place in sample: 
LIGHTCOinoxyluciferPPAMPinOxyluciferOluciferinDATP i
Mgluciferase ????????? ????? ? 2/2
2
 
The emitted light intensity is linearly related to the amount of ATP and is measured 
using a luminometer Fluoroscan Ascsw26. 
 
HepG2 cells from three different passages were tested for mycoplasma. Negative and 
positive controls were used. The results are shown in Table 2. According to the results, 
no mycoplasma was detected in HepG2 cells.  
 
Table 2: Mycoplasma test results. Mycoplasma was tested according to instructions and 
the ratios calculated are shown. There was no mycoplasma in the samples, since the 
ratios are about or below or close to one.  
 Ratio  
Negative control 0.375 
Passage 4 0.775 
Passage 5 1.023 
Passage 6 0.797 
Positive control 96.96 
 
 
Primary Rat Hepatocytes 
The culture conditions for primary rat hepatocytes have been optimized before at Orion 
Pharma. These conditions (cell density, culture plates and culture medium) were 
evaluated for HCS assays and found to be appropriate.  
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10.2 Optimization of live cell method 
 
To optimize live cell method four different nucleus dye Hoechst 33342 concentrations 
were used: 0.2, 0.4, 0.8 and 1.6 µM (table 3). Both primary rat hepatocytes (results 
below) and HepG2 cells (results not shown) were tested. Images were analyzed using 
20x objective, and the automatic exposure times for each concentration were as follows:   
 
Table 3: The exposure times for Hoechst 33342 staining. 
Hoechst 33342 
Conc 
0.2µM 0.4µM 0.8µM 1.6µM 
Exposure time 0.301 sec 0.209sec 0.081sec 0.03sec 
 
Similarly, four different concentrations for the mitochondrial membrane potential probe 
TMRM were used: 5 / 10 / 20 / 40 nM, and analyzed with 20x objective. The exposure 
times for each concentration were as follows (table 4). 
 
Table 4: Exposure times for TMRM . 
TMRM Conc 5nM 10nM 20nM 40nM 
Exposure time 0.059 sec 0.043sec 0.025sec 0.016sec 
 
Exposure  times  vary  depending  on  the  dye  concentration.  They  are  also  dependent  of  
the  treatment  of  the  cells,  the  cell  model,  the  objective  and  the  plate.  Therefore,  the  
exposure times must be tested for each assay separately. The signal must be strong 
enough to be detectable, but not over-exposured. Exposure times and probe 
concentrations should be kept as low as possible. High probe concentrations and long 
exposure times may cause phototoxicity to the cells. Too strong fluorescence signal may 
lead to the poor quality of the image and the intensities cannot be measured reliably. 
Based on the results, 0.8µM Hoechst 33342 and 20nM TMRM were decided to use for 
both  HepG2  cells  and  rat  primary  hepatocytes.  These  are  also  commonly  used  
concentrations of these probes in previous studies (O’Brien et al 2006). Figures of the 
live cell method with treated or untreated primary rat hepatocytes are shown in figures 
11(nucleus) and 12 (mitochondria). In figure 11 nucleus is stained with 0.8µM Hoechst 
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33342 and in figure 12 mitochondria is stained with 20nM TMRM. In both figures 
untreated cells are on the left, 2.5µM, 24h staurosporine treated cells are on the right. 
Figures have been taken with 20x objective two days after plating. 
 
Figure 11: Primary rat hepatocytes’ nucleus using live cell method. Cells have been 
stained with 0,8µM Hoechst 33342, untreated cells are on the left and 2.5µM 
staurosporine for 24h treated cells on the right. Figures have been taking using 
Cellomics ArrayScan and 20x objective two days after plating.  
 
 
 
Figure 12: Primary rat hepatocytes using live cell method. Cells have been stained with 
20nM TMRM, untreated cells are on the left and 2.5µM staurosporine for 24h treated 
cells on the right. Figures have been taking using Cellomics ArrayScan and 20x 
objective two days after plating.  
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The  challenge  with  test  compound  treated  cells,  especially  those  with  higher  drug  
concentrations, was that when cells undergo apoptosis the nuclei are condensed and the 
signal of the probe in nucleus is growing. Therefore, adjusting the exposure times was 
challenging: when exposure time was appropriate for the samples with lower 
concentrations of the test compound the image of the cells with higher concentrations is 
easily over-exposured. Further, over-exposured images cannot be analyzed reliably as 
seen in figure 13, setting the parameters so that both normal and over-exposured nuclei 
are recognized is difficult. This was also the situation with fixed cells (data or figures 
not shown). 
 
Figure 13: Primary rat hepatocytes stained with 0.8 µM Hoechst 33342. On the left 
control cells (1% DMSO) and on the right cells incubated with 5µM rotenone for 24h. 
Signal in apoptotic nuclei is higher which may cause problems in object identification 
by making it difficult to set the parameters so that the nuclei of the untreated cells are 
also identified. 
 
 
10.3 Optimization of fixed cell method 
 
Five  different  concentrations  of  Mitotracker  Red  CMXRos  were  compared:  50  /  75  /  
100 / 150 / 200nM. Cells were scanned with Cellomics ArrayScan using automatic 
exposure time. Both HepG2 cells and primary rat hepatocytes were tested. The 
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concentration with good signal and low enough exposure time was chosen to 
experiments. This concentration was 100nM. 
 
Three different concentrations for cytochrome c primary antibody were used: 1:150, 
1:300, 1:450. Alexa 488 conjugated secondary antibody was all the time the same 
concentration: 1:150. Based on the results, primary antibody was chosen to use in a 
concentration of 1:300. 
 
Figures of the fixed cell method with treated or untreated primary rat hepatocytes are 
shown in figures 14 (nucleus) and 15 (mitochondria). In figure 14 nucleus is stained 
with 0.8µM Hoechst 33342 and in figure 15 with 1:300 primary antibody (cytochrome c 
antibody) and with 1:150 alexa 488 conjugated secondary antibody. In both figures 
untreated cells are on the left, 2.5 µM, 24h rotenone treated cells are on the right. 
Figures have been taken with 20x objective two days after plating. 
 
 
 
Figure 14: Primary rat hepatocytes’ nucleus using fixed cell method. Cells have been 
stained with 0,8 µM Hoechst 33342, untreated cells are on the left and 2.5 µM 
staurosporine for 24h treated cells on the right. Figures have been taking using 
Cellomics ArrayScan and 20x objective two days after plating.  
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Figure 15: Primary rat hepatocytes using fixed cell method. Cells have been stained 
with with 1:300 primary antibody (cytochrome c antibody) and with 1:150 alexa 488 
conjugated secondary antibody, untreated cells are on the left and 2.5 µM staurosporine 
for 24h treated cells on the right. Figures have been taking using Cellomics ArrayScan 
and 20x objective two days after plating.  
 
 
A problem with fixed primary hepatocytes was the dead cells that were stuck on the cell 
layer already when the cells were seeded after perfusion. Washing of the cells with PBS 
helped somewhat to get rid of the dead cells but not all of them could be excluded. Dead 
cells were seen both in mitochondria (probe uses with Mitotracker Red CMXRos) and 
cytochrome c (probe used cytochrome c-antibody and alexa 488-conjugated secondary 
antibody)- channels (channels 2 and 3) when cells were scanned with Cellomics 
ArrayScan, this is seen in figure 16. To get rid of the false signal caused by the dead 
cells the parameters were set so that the intensities over the adjusted limit were ignored 
from the image analysis (parameters seen in tables 6 and 7).  
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Figure 16: Control cells (1% DMSO) stained with Mitotracker Red CMXRos and fixed 
(see methods part). The bright spots in the image are dead cells disturbing the image 
analysis. 
 
 
With fixed cell method the “blurring” of cell structures after fixing and permeabilization 
of the cells caused problems. This was solved by testing in which part of the protocol 
the signal is starting to “blur” and leake by staining the cells according to protocol but 
scanning them after each step to see the changes. Cells were stained with only Hoechst 
33342, with Hoechst 33342 and Mitotracker Red CMXRos, with Hoechst 33342 and 
cytochrome c-antibody or with all three probes. The reason for leakage of the probes 
was not precisely found, but obviously the basic problem was the fixation protocol, 
because the Mitotracker Red CMXRos signal was bright before fixation and blurred 
after fixation. This meant that the signal changed most radically after permeabilization 
(data or figures not shown). This would lead to conclusion that the permeabilization 
stage should have been optimized more, which was not possible due time limits.  Due to 
this problem it was decided not to use Mitotracker Red CMXRos-stain in the analysis, 
and thus the analysis was done with cytochrome c-localization, measuring the intensity 
of  the  spots  in  the  area  of  nuclei  and  comparing  it  to  the  intensity  of  the  spots  at  the  
cytoplasm area. 
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10.4 Image acquisition and analysis with the Cellomics 
ArrayScan VTI Reader 
 
In practical, scanning with Cellomics ArrayScan follows the certain routines. First the 
plate is placed into the instrument, and the assay protocol is selected. As explained later, 
channel 1 is used to focus the image. Images are acquired from all the channels used, 
and the quality of the images and proper focus is checked. Exposure time and objective 
used (10x, 20x or 40x) are defined so that the parameters to be measured can be 
identified in all the cells on the plate with different treatments. Correct filter channels, 
objective, focus plain and exposure times are critical for good image analysis and they 
cannot be changed afterwards. Other input parameters can be changed and optimized 
later using the existing image. 
 
10.4.1 Input parameters 
 
In this study Hoechst 33342- stained nuclei of the cells were identified in the channel 1 
as primary objects. Channel 1 objects are also used to focus the microscope during the 
experiment. Parameters for this channel can be measured as either total or average 
intensity or certain morphological changes of the nuclei. Three nuclear parameters were 
measured in this study. First, the stained nuclei were used to count the number of the 
nuclei in each microscopy field. In hepatocytes, there are often two nuclei in one cell, 
and therefore the exact number of cells could not be measured. The second parameter 
measured was the average intensity of fluorescence of the nuclei. Intensity of 
fluorescence is higher in apoptotic nuclei comparing to healthy cells. The third 
parameter measured was the area of the nuclei, which is smaller in apoptotic nuclei than 
in healthy ones. 
 
Parameters for channel 2 measure the intensity of the mitochondria or intensity ratio 
between mitochondria and nucleus. Total or average intensity are possible to measure. 
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The total intensity is the sum of the intensities of all the individual pixels in the region. 
The average intensity is equal to the total intensity divided by the number of pixels in 
the region. The effect of parameters for each analysis is described separately for primary 
rat hepatocytes and for HepG2 cells because each cell type displayed a distinct 
morphology and staining properties. All the parameters used in scans are listed in the 
Tables 5, 6 and 7. 
 
Object identification methods 
Object identification methods are used to identify objects. In this study, the image 
analysis software recognises all the nuclei, but ignores the background signal.  The 
accurate set of object identification parameter is a requirement for proper quantitative 
analysis of the assay. Different identification methods for each channel are explained in 
detail  below.  The  aim of  the  object  identification  is  to  set  parameters  so  that  only  the  
pixels that are above the threshold will be taken into analysis and the pixels below are 
left away.   
 
Fixed threshold determines the actual intensity of the image and it is set independently 
of the image data. When the certain value is set, all the intensity below the value given 
is excluded. Isodata and triangle thresholds are known as histogram-derived thresholds 
that are dependent on the pixel intensities in the image. The equation used to determine 
the actual threshold (Tf) is as following: Tf=(1+o)T, where o is the user-entered offset 
value. In Cell Health Profiling bioapplication Isodata Threshold method is not possible 
to use. The examples of the object identification are shown in figure 17. In figure there 
is shown how objects are identified at Cellomics ArrayScan. Cells are untreated primary 
rat hepatocytes, nucleus on the left are stained with 0.8µM Hoechst 33342 and 
mitochondria on the right with 20nM TMRM. Figures have been taken two days after 
plating with Cellomics ArrayScan and 20x objective. The examples of the defined 
parameters are on the left, the yellow ring around one nucleus represents the nucleus 
that is too big to be included into the analysis. This excludion is done with object area-
parameter on channel 1. 
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For  primary  rat  hepatocytes  triangle  threshold  was  decided  to  use  as  object  
identification method for channel 1 in Compartmental Analysis -bioapplication. When 
comparing the three object identification methods, fixed threshold did not identify 
nuclei properly in the image analysis. For HepG2-cells fixed threshold was the method 
used in channel 1 in Compartmental Analysis –bioapplication since it identified nuclei 
better than other triangle threshold method in these cells. In Cell Health Profiling -
bioapplication Fixed Treshold was used for both primary rat hepatocytes and HepG2-
cells in channel 1 (Hoechst 33342).  
 
For channel 2 fixed threshold was the method used for both bioapplications and cell 
types. In Compartmental Analysis object identification method for channel 2 is not a 
crucial parameter, because the information is gained by comparing the ring and circ 
values. In Cell Health Profiling-bioapplication when fixed threshold was compared to 
Isodata threshold and no object identification method at all, fixed threshold identified 
mitochondria the best.  
 
Basic assay parameters 
These assay parameters must be set carefully, because they control image acquisition 
and object identification in the microwell plate. If image analysis parameters are not set 
properly, it can cause systematic errors for the image analysis and results interpretation. 
These parameters are common for both bioapplications used. 
 
Background correction: This parameter is one of the most important parameter affecting 
the object identification. It can be negative or positive. Method for background 
correction with positive values means that the local minimum in the certain region of 
the  well  is  specified  by  the  value  entered  and  it  is  subtracted  from  that  region  of  the  
image. With negative background correction values the local minima is detected and it 
is  used  to  fit  a  surface  representing  the  background,  which  is  then  subtracted.  
Automated surface fitting is also possible; in this case the value of the background 
correction is -1. In these assays positive background correction values were better than 
negative for object identification in channel 1. For channel 2 background correction 
parameters vary depending on the bioapplication used. For Cell Health Profiling 
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(channel 2) negative values identified mitochondria better than positive values, and 
negative values were used. In Compartmental Analysis negative values were used with 
HepG2 cells, whereas positive values were used with primary rat hepatocytes.  
 
Object smoothing: Object smoothing factor -parameter enables the control of the degree 
of the image smoothing before the identification of objects. Smoothing is useful if 
fragments of objects are wanted to be connected, and it can be valuable when measuring 
morphological changes. The parameter can have values ranging from 1 to 127, and the 
bigger the value, the more smoothing is done. Insufficient smoothing can result in 
unwanted object fragmentation, whereas excessive smoothing may cause poor 
definition of the primary object. Too high values can cause for example two nuclei close 
to each other to be identified as one.  If  sharp definition of the edges is  desirable as in 
Cell Health Profiling and Compartmental Analysis – bioapplications, it is best to keep 
the value as small  as possible if  not 0.  Here,  the parameter value 1 was used in every 
analysis.   
 
Object segmentation: Object segmentation parameter helps in resolving individual 
objects if needed. Object segmentation is a very useful parameter in a situation when 
cells are in clumps or densely packed so that they touch each other. Object segmentation 
parameter can have values from -255 to 255, and depending on the value the objects are 
identified based on either geometry or peak intensity of the object, positive value being 
geometric identification and negative peak intensity identification. Geometric 
identification is based on shape and is useful if objects have boundary indentations. 
Peak intensity separates objects according to their intensity and is good in situations 
where objects do not have boundary indentations. The cell confluence in these studies 
was optimized so that the minimal object segmentation would be needed here. Only 
positive values were used because these values gave better mask than negative. Too 
small values for the parameter (1-5) caused too much separation, whereas 5-10 was 
appropriate. With HepG2-cells, which were more confluent than primary hepatocytes, 
smaller values gave better results. The values used in this study are seen in tables 5, 6 
and 7. 
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Object type: Object type parameter specifies whether the objects of interest are brighter 
or darker than the background of the image. In both bioapplications the objects are 
brighter than the background. The value of the parameter is 1 or 0, 1 meaning the object 
being brighter than the image and 0 is the opposite situation. Object type parameter 
value 1 was used here in all situations. 
 
Reject Border Objects: This parameter can be either 1 or 0,  when this is  1 the objects 
that are in the edges of the image are not taken into account when analyzing results. The 
situation is the opposite when the parameter is 0.  
 
Object Area: Object area-parameter defines the area of the object. Object area was used 
to measure the size of nucleus on channel 1 as a marker of cytotoxicity. The minimum 
and maximum areas were given to exclude objects that were not real objects, e.g. local 
intensity maxims that were not nucleus but just some impurity. 
 
Channel-specific assay parameters 
Channel-specific assay parameters are parameters that are set to each channel 
separately. Unlike Object Identification- and Basic Assay parameters, each 
bioapplication has its own channel-spesific assay parameters. 
 
In Cell Health Profiling – bioapplication Channel-spesific assay parameters are used to 
define the extents of measurement regions. Measurement region in channels 2-4 can be 
set to be either circ or ring, in channels 5-6 only circ is possible. The size of the circ or 
ring is related to the primary object in channel 1.  
 
Target ring width –parameter is used to choose between the circ and ring region. If the 
value is 0, circ is chosen and it can be modified with Target circ modifier-parameter. In 
these experiments parameter 1, meaning ring region, was used. The width of the ring 
was set as large as possible to get all the area of the mitochondria into the analysis.  
 
Target ring distance – parameter defines the number of pixels which is left between 
outer boundary of the circ and inner boundary of the ring. This is explained below. 
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Target circ modifier –parameter is used in modifying the circ region in case that circ 
region is used. It determines the region correlated to object. 
 
Mask modifier – parameter is used in controlling the modification of the object mask 
used for gating.  
 
Average intensity and Total intensity – parameters define the intensity maximum and 
minimum of the ring / circ region. 
 
For Compartmental Analysis – Bioapplication channel spesific assay parameters help in 
adjusting cellular regions, circ and ring, in channels 2-6. The size of these regions can 
be adjusted independently for each channel when needed. In this experiment the area of 
the circ and ring played a crucial role since the difference of the spots in the nucleus vs. 
in the cytoplasm was the parameter measured. 
 
Circ modifier – parameter is used to set the circ region. The value is the number of 
pixels that are dilated (positive value) or eroded (negative value) from the perimeter of 
the primary object to define the area covered by the circ region.  
 
Ring distance – parameter determines the distance of the ring from circ. When this is 0, 
the ring region starts where circ area ends. With positive ring distance -values the 
number of pixels is added to the perimeter of the primary object and with negative 
values subtracted, to define the inner boundary of the ring region. In this analysis the 
value of ring distance was set small, because if the value is too high, the spot which in 
real is in cytoplasm is counted to be in nucleus.  
 
Ring width – parameter determines the ring width in pixels where spots are counted.  
 
Spot kernel radius – parameter separates the background signal from spots measured 
from circ/ring-region. 
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Ring average intensity and Circ average intensity – parameters determines the average 
intensity  of  the  ring  or  circ,  its  maximum  and  minimum.  Circ  average  intensity  was  
used to measure the intensity in the circ area, as a marker of leaked cytochrome c from 
cytosol to circ area. 
 
Circ/ring average intensity difference and Circ/ring average intensity ratio - parameters 
are used to define the minimum and maximum intensity differences (circ intensity – 
ring intensity) and ratios (circ intensity / ring intensity). Maximum values were used to 
get rid of the dead cells with primary rat hepatocytes in channel 2 that might have 
bothered the analysis when having too high intensities. 
 
Ring spot total area and Ring spot average intensity - parameters are used to define the 
maximum area and intensity of the ring. 
 
Circ spot total area and Circ spot average area - parameters are used to define the total 
and average area of circ spots. 
 
Average intensity and Total intensity- parameters are used in defining maximum and 
minimum intensities of the circ / ring –region. 
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Table 5: Optimized input parameters for channel 1 (Ch1, Hoechst 33342 staining) 
using Compartmental Analysis -bioapplication for fixed cells (PH fix; fixed Primary 
rat hepatocytes, HepG2 fix; fixed HepG2 cells) and Cell Health Profiling –
bioapplication for live cells (PH live; live primary rat hepatocytes, HepG2 live; live 
HepG2 cells). Object identification method & value, background correction, object 
segmentation, object smoothing factor, object type, reject border objects, and object 
area parameters were defined. Default values for object shape, object average intensity 
and object total intensity were used since no limitation for object identification was 
needed using these parameters for channel 1. 
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Table 7: Optimized input parameters for channel 2 using Cell Health Profiling –
bioapplication for live cells (PH live for primary rat hepatocytes, HepG2 for HepG2 
cells. Parameters  are explained in detail in the text. Object identification method & 
value, background correction, object type and target ring distance parameters were 
defined.  Default values for target ring width, target circ modifier, mask modifier, 
average intensity and total intensity were used since no limitation for object 
identification was needed using these parameters for channel 2. 
Table 6: Optimized input parameters for channel 2 using Compartmental Analysis -
bioapplication for fixed cells (PH fix; fixed Primary rat hepatocytes, HepG2 fix; fixed 
HepG2 cells). Parameters are explained in more detail in the text. Object identification 
method & value, background correction, spot kernel radius, target ring distance, target 
ring width, ring average intensity and circ average intensity parameters were defined. 
Default values for circ/ring average intensity difference, circ/ring average intensity 
ratio, ring spot total area, ring spot average intensity, circ spot total area, circ spot 
average area, average intensity and total intensity were used since no limitation for 
object identification was needed using these parameters for channel 2. 
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20x Fixed 127 -100 1 0 0-127 0 0 0-32767 0-10^8 
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Figure 17: Figures from Cellomics ArrayScan and how objects are identified at 
Cellomics ArrayScan. Cells are untreated primary rat hepatocytes, nucleus on the left 
are stained with 0.8 µM Hoechst 33342 and mitochondria on the right stained with 
20nM TMRM. Figures have been taken two days after plating with Cellomics 
ArrayScan and 20x objective with values defined in tables 5 and 7. The example of the 
effect of the defined parameter is on the left, the yellow ring around one nucleus 
represents the nucleus that is too big to be included into the analysis. This excludion is 
done with object area-parameter on channel 1.  
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10.4.2 Cellomics ArrayScan scanning results and output parameters 
 
After input parameters were selected, the required objective and the optimal output 
parameters for each assay were chosen. The amount of the fields used in the scans was 
decided to be 5 fields in each well since more fields would have caused too long 
scanning  times.  In  HCS time is  one  of  the  most  important  things  that  matter.  HCS is  
made to quicken toxicity screening and also because of the probes used in the 
experiments are good to carry out as quickly as possible. In this experiment different 
Cellomics ArrayScan objectives were tested to find out the most rapid way to perform 
experiment without losing the sensitivity of the protocol. Scanning live cells with 
Cellomics Arrayscan VTI took less time than scanning fixed cells. Since the more 
channels used the more time it  takes to scan. Of the three objectives available the 10x 
objective was selected since it measured more cells per field and therefore the standard 
deviations were smaller than with the 20x or 40x objective (examples of the 
comparisons between different objectives are shown in figures 18 and 19: examples 
with 2h rotenone treated live cells and 24h staurosporine treated fixed cells). 
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Figure 18:  Comparison  of  Cellomics  ArrayScan  Scan  results  with  10x,  20x  and  40x  
objectives using live cell method and 2h rotenone treated rat primary hepatocytes 
(experiment 20091111). The parameter measured is the average intensity of the channel 
2, which measures the intensity of the mitochondrial membrane potential probe 
(TMRM)  and  correlates  to  the  condition  of  mitochondria.  Results  are  shown  as  %  of  
control ±SD, control being 100%. 
 
 
Figure 19: Comparison of Cellomics ArrayScan Scan results with 10x, 20x and 40x 
objectives using fixed cell method and 24h staurosporine treated primary rat 
hepatocytes (experiment 20091204). This parameter (circ/ring average intensity 
difference) detects the leaking of cytochrome c from damaged mitochondria by 
measuring its translocation from cell cytoplasm (ring) to nucleus (circ) area. Results are 
shown as % of control ±SD, control being 100%. 
 
The sensitivity of the 10x objective was very close to the objectives with higher 
resolution. In addition, scanning with 10x objective took less time than scanning with 
20x objective, which in turn took less time than scanning the cells with 40x objective. 
This is because the focusing time is longer with bigger objectives when there are more 
details and higher possibility to try to focus on an empty spot. The approximate 
scanning times for live cells were 10 – 20 minutes / a full 96 well plate using 10x 
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objective. The scanning times for fixed cells were at least the double the time than with 
live cells because more channels were used with fixed cells. 
 
After choosing the objective, the output parameters for each assay were chosen. With 
live cells object average intensity and target area parameters were compared (example 
of the comparisons is shown in figure 20: example using 2h rotenone treated cells). Also 
the nucleus parameters (nucleus average intensity and nucleus count) were compared to 
these mitochondrial parameters to see the correlation between nucleus and mitochondria 
(data not shown). The main focus was still to find the proper mitochondria parameter.  
For live cells, object average intensity was chosen to use. With fixed cells circ average 
or total intensity and circ/ring average intensity difference and ratio were compared 
(examples of the comparisons are shown in figures 21 and 22: examples using 2h 
rotenone treated cells).  
 
 
Figure 20: Comparison of the output parameters for the live cell method in 2h rotenone 
treated primary rat hepatocytes using 10x objective (experiment 20091111). Parameters 
that were compared were target area and target average intensity of channel 2 which 
measures the intensity of the mitochondrial membrane potential probe (TMRM) and 
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correlates to the condition of mitochondria. Results are shown as % of control ±SD, 
control being 100%. 
 
For fixed cells circ average intensity parameter was decided to use. This parameter for 
fixed cells and object average intensity- parameter for live cells were chosen because 
they were the most sensitive. In addition, they both showed slightly smaller standard 
deviations than the other parameters compared. With fixed cells there were no big 
difference between the two parameters, circ average intensity and circ total intensity. 
With these parameters the smaller sd:s with average intensity-parameter was the reason 
that this parameter was chosen to use (This is seen in figure 22). 
 
 
Figure 21: Comparison of the output parameters for the fixed cell method in 2h 
rotenone treated primary rat hepatocytes using 10x objective (experiment 20091106). 
The parameters that were compared were circ average intensity, circ total intensity and 
circ/ring average intensity ratio of the alexa 488, which is linked to cytochrome c 
through antibodies.  These parameters detect the leaking of cytochrome c from damaged 
mitochondria by measuring its translocation from cell cytoplasm to nucleus area. 
Results  are  shown  as  %  of  control  ±SD, control being 100%. See figure 22 for more 
information. 
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Figure 22: Comparison of the output parameters for the fixed cell method in 2h 
rotenone treated primary rat hepatocytes using 10x objective (experiment 20091106). 
This is the same figure as figure 21 but without Circ/Ring ratio – parameter. The 
parameters that were compared were circ average intensity and circ total intensity of the 
alexa 488, which is linked to cytochrome c through antibodies.  These parameters detect 
the leaking of cytochrome c from damaged mitochondria by measuring its translocation 
from cell  cytoplasm to  nucleus  area.  Results  are  shown as  % of  control  ±SD, control 
being 100%. 
 
From the two cell models compared primary rat hepatocytes were chosen to use in the 
final comparisons. This was because they were more sensitive to the test substances 
used than did HepG2-cells (example of the comparisons in figure 23: example using 2h 
rotenone treated cells). In addition, HepG2 cells lack most xenobiotic metabolism 
activity compared to the primary cells as discussed in more detail in section 8.1.1: Cell 
Models (Westerink and Schoonen 2007a and 2007b). Further, the confluences between 
analyses vary with HepG2-cells and the amount of cytosol is smaller compared to the 
primary hepatocytes. Thus the setting of the input parameters was more difficult using 
HepG2 cells.     
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Figure 23: The comparison of primary rat hepatocytes and HepG2-cells (Experiments 
20091111 and 20091208) using live cell method, with 2h rotenone treated cells and 10x 
objective.  Results  are  shown  as  %  of  control,  control  being  100%.  Parameters  that  is  
shown here is the target average intensity of the channel 2 which measures the intensity 
of the mitochondrial membrane potential probe (TMRM) and correlates to the condition 
of mitochondria. Results are shown as % of control ±SD, control being 100%. 
 
The next step was to compare and make a choice between live and fixed cell methods. 
Live cells were the cells chosen to be used in the final comparisons, since live cell 
method was more sensitive (examples of the comparisons are shown in the Figure 24: 
example using 2h rotenone treated cells). In addition the live cell method protocol was 
faster and easier to use and with fixed cells there were problems with fixation itself 
(discussed in more detail in section 10: Discussion). In experiments (and as seen in 
figure 24) Target Average Intensity is the main parameter measured in the live cell 
method and Circ Average Intensity in the fixed cell method. 
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Figure 24: The comparison of fixed and live cell method using 2h rotenone treated 
primary rat hepatocytes and 10x objective (Experiments 20091111 and 20091113). 
Target Average Intensity is the main parameter measured in the live cell method and 
Circ Average Intensity in the fixed cell method. Target average intensity of channel 2 
measures the intensity of the mitochondrial membrane potential probe (TMRM) and 
correlates to the condition of mitochondria. Circ average intensity measures the 
intensity of the alexa 488, which is linked to cytochrome c through antibodies and 
detects the leaking of cytochrome c from damaged mitochondria. Results are shown as 
% of control ±SD, control being 100%.   
 
After the parameters, the cell type and the method were selected the scans were made 
and the results were compared to conventional cytotoxicity methods results. The 
following figures are the results of the chosen method (live cell method) and parameters 
(target average intensity). In figures 25, 28 and 31 all three test compounds’ 
mitochondria intensities are shown in separate figures but still showing each timepoint. 
The  nucleus  intensity  and  amount  are  shown  in  the  same  manner  as  mitochondria  
intensities (each drug compound in each timepoint in separate figures) in figures 26, 29 
and 32 (nucleus intensities) and 27, 30 and 33 (nucleus counts) to see how those 
parameters correlates to the condition of mitochondria. Nuclei typically condense in 
apoptotic cells and therefore the average intensity of the stained nuclei can be measured 
to detect the level of apoptosis. As seen in figures 27, 30 and 33 nucleus count was not 
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the best possible parameter to measure cytotoxicity. The increase in the amount of 
nucleus correlates maybe with the improper object identification. In each timepoint 
there were three concurrent samples and three concurrent experiments. 
 
With three test compounds the toxic effects were seen already after 2h incubation: this 
was the situation especially with staurosporine and rotenone. The effects were seen 
especially when looking the pictures from Cellomics ArrayScan: the effects are not that 
clearly seen in output data (will be discussed in more detail in discussion-part). The 
toxic effects evaluated by eye were usually seen as the cells were either detached from 
the bottom of the well, nuclei were tiny sized and really condensed (measured with 
average area / average intensity of channel 1: the intensity was growing and area was 
reducing) or the mitochondrial membrane potential in the channel 2 was reducing 
(parameter measured average intensity of the channel 2). 
 
Staurosporine showed toxicity with even smallest concentrations after 2h incubation. 
The intensity of the mitochondria often increased with lower drug concentrations but 
drop down with higher concentrations, e.g. with 2.5µM (63% of control). After 24h 
incubation cells were usually totally dead (according to brightfield images) with three 
(sometimes four) highest concentrations: 5, 2.5 and 1.25µM. The toxic effect of 
staurosporine was seen both in nuclei and mitochondria, and the condensation of the 
nucleus was visually detectable even with 0.0078µM (107% of control) concentration 
and after 2h incubation, sometimes even more clearly than the mitochondrial effects. 
The intensity of the mitochondria with staurosporine is shown in figure 26. Also the 
effect of staurosporine to mitochondria intensity was surprising after 24h exposuring. 
Intensity should be decreasing as it is after 2h and 6h incubation, but after 24h 
incubation the intensity is controversially growing. This was most likely because the 
cells were dead after that long incubation and the input parameters were not optimal to 
detect the dead cells. This is also supported by the high variation of the results. 
 
The toxic effect to nucleus was measured by nucleus average intensity-parameter, the 
results are shown in figure 26 where the intensity of the nucleus is being measured. As 
seen in figure 26, intensities of the nuclei were so intense after 24h incubation that they 
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were often over-exposed (meaning that the exposure time was set according to control 
cells, in condensed nuclei this appears as over exposuring), that might further cause the 
object  identification  to  fail.  The  intensity  of  the  nucleus  grows  when  it  condenses,  as  
mentioned previously in text. The nucleus count is shown in figure 27.  
 
 
Figure 25: Cellomics  ArrayScan  scan  results  with  chosen  method  (live  cell  method),  
output parameter (target average intensity of channel 2; measures the mitochondrial 
membrane  potential),  cells  (primary  rat  hepatocytes)  and  objective  (10x).  Cells  are  
treated with staurosporine for 2, 6 or 24h. Results  are  shown  as  %  of  control  ±SD,  
control being 100%.    
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Figure 26: Cellomics ArrayScan scan results with chosen method (live cell method), 
cells (primary rat hepatocytes) and objective (10x), showing nucleus parameter nucleus 
average intensity (channel 1, nuclei were stained with 0.8µM Hoechst 33342). In 
apoptotic cells, nuclei typically condense: this can be detected by measuring the average 
intensity  of  the  stained  nuclei.  Cells  are  treated  with  staurosporine  for  2,  6  or  24h.  
Results are shown as % of control ±SD, control being 100%.   
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Figure 27: Cellomics ArrayScan scan results with chosen method (live cell method), 
cells (primary rat hepatocytes) and objective (10x), showing nucleus count (cells stained 
channel 1 with 0.8µM Hoechst 33342). Cells are treated with staurosporine for 2, 6 or 
24h. Results are shown as % of control ±SD, control being 100%.    
 
With rotenone the results were quite similar than with staurosporine. The toxicity was 
seen after 2h incubation with 0,625µM concentration (85% of control) but not that 
much with lowest concentrations, 0.0078µM and 0.0325µM (98% and 95% of control). 
In 6h timepoint these concentrations showed more toxicity visually and after 24h 
incubation  cells  were  usually  totally  dead  with  two  or  three  highest  concentration.  
Despite the fact that these effects were visually clear, effects are not always seen in 
numeric data: e.g. in figure 28 2h timepoint is the most sensitive according to Cellomics 
ArrayScan  results.  After  6h  and  24h  timepoints  anyway,  the  toxic  effects  of  rotenone  
(cells that are already dead) may cause the unexpected changes in intensities and 
consequently into results as seen in figure 28 (mitochondria intensity).  
 
The condensation and fragmentation of nucleus was not that clear than with 
staurosporine, but visually detectable. These nuclear results are shown in figure 29 
(nucleus intensity) and figure 30 (nucleus count). As with staurosporine, rotenone 
showed toxicity by condensing the nuclei, this is seen as higher intensities in figure 29. 
73 
 
The toxic effect of rotenone is pretty clear: after 2h incubation the intensities are not 
that high than after 6h incubation. After 24h nucleus intensity is diminishing most likely 
due to cell death. Nucleus count with rotenone is shown in figure 30. Results of nucleus 
count were somewhat unexpected: The amount of nuclei increased after 2h incubation 
when comparing to control. However this might again be explained by improper object 
identification. The amount of nucleus after 24h incubation was about the half of the 
control with all concentrations (54-39% of the control): as discussed above for nuclei 
intensity this supports the estimation that the cells were most likely already dead. 
 
 
Figure 28: Cellomics  ArrayScan  scan  results  with  chosen  method  (live  cell  method),  
output parameter (target average intensity of channel 2; measures the mitochondrial 
membrane  potential),  cells  (primary  rat  hepatocytes)  and  objective  (10x).  Cells  are  
treated with rotenone for 2,  6 or 24h. Results are shown as % of control ±SD, control 
being 100%.    
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Figure 29: Cellomics ArrayScan scan results with chosen method (live cell method), 
cells (primary rat hepatocytes) and objective (10x), showing nucleus parameter nucleus 
average intensity (channel 1, nuclei were stained with 0.8µM Hoechst 33342). In 
apoptotic cells, nuclei typically condense and it can be detected by measuring the 
average intensity of the stained nuclei. Cells are treated with rotenone for 2, 6 or 24h. 
Results are shown as % of control ±SD, control being 100%.      
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Figure 30: Cellomics ArrayScan scan results with chosen method (live cell method), 
cells (primary rat hepatocytes) and objective (10x), showing nucleus count (cells stained 
channel 1 with 0.8µM Hoechst 33342). Cells are treated with rotenone for 2, 6 or 24h. 
Results are shown as % of control ±SD, control being 100%.      
 
Tolcapone was the drug not showing that clear toxicity after 2h and 6h incubation. After 
24h incubation the toxic effects were already seen with lowest drug concentrations 
(0.078, 0.325 and 0.65µM: 103%, 98% and 97 % of control, respectively). The intensity 
of the mitochondria (channel 2) after 2, 6 or 24h incubation with tolcapone is shown in 
figure 31. With tolcapone the mitochondrial effects were more clear marks of toxicity 
than nucleus fragmentation or condensation. The intensities of the nuclei after 2h 
incubation was mildly increasing with all drug concentrations: this was the situation 
also after 6h incubation. After 24h incubation the intensities of the nuclei decreased 
surprisingly, reason for this is unknown since the intensity didn’t seem to decrease 
visually. Also the nucleus count was weird: the amount of nucleus (and cells) decreased 
after 2h incubation with all concentrations. After 6h incubation the amount of nucleus 
increased  and  after  24h  did  not  show any  clear  effects:  these  results  were  maybe  due  
inappropriate method optimization and object identification. Figure 32 shows the 
intensity of the nucleus and 33 shows nucleus count. 
 
76 
 
  
Figure 31: Cellomics  ArrayScan  scan  results  with  chosen  method  (live  cell  method),  
output parameter (target average intensity of channel 2; measures the mitochondrial 
membrane potential which should reduce as cells go through apoptosis), cells (primary 
rat hepatocytes) and objective (10x). Cells are treated with tolcapone for 2, 6 or 24h. 
Results are shown as % of control ±SD, control being 100%.    
 
 
77 
 
Figure 32: Cellomics ArrayScan scan results with chosen method (live cell method), 
cells (primary rat hepatocytes) and objective (10x), showing nucleus parameter nucleus 
average intensity (channel 1, nuclei were stained with 0.8µM Hoechst 33342). In 
apoptotic cells, nuclei typically condense and it can be detected by measuring the 
average intensity of the stained nuclei. Cells are treated with tolcapone for 2, 6 or 24h. 
Results are shown as % of control ±SD, control being 100%.      
 
 
Figure 33: Cellomics ArrayScan scan results with chosen method (live cell method), 
cells (primary rat hepatocytes) and objective (10x), showing nucleus count (cells stained 
channel 1 with 0.8µM Hoechst 33342). Cells are treated with tolcapone for 2, 6 or 24h. 
Results are shown as % of control ±SD, control being 100%.      
 
 
10.4 Conventional analysis of cytotoxicity 
 
Primary rat hepatocytes showed slight cytotoxicity using ATP and LDH measurements 
already after 2 hours incubation with all three test compounds.  
 
Cytotoxic effect of staurosporine was moderate after 2 hours of incubation (Figure 34). 
The ATP levels rose with lower concentrations (from 0.078µM to 1.25µM: from 100 to 
110% of  control)  but  drop  down with  5µM (62% of  control).  The  rose  in  ATP levels  
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was not seen that clearly after 6 or 24h incubation, thus the ATP levels drop down with 
lowest concentrations. The rose in ATP may correlate to the condition of the cells, when 
they produce more ATP trying to maintain cellular functions. The cytotoxicity was seen 
more in decrease of ATP levels than in increase of LDH levels at least in timepoints 2 
and 6 hours, after 24h incubation LDH showed more toxicity. With LDH the same kind 
of  effect  (but  opposite)  was  seen  than  with  ATP  levels,  LHD  levels  drop  down  with  
smallest concentrations after 2h incubation, but rose with 2.5µM and 5.0µM (148 and 
157% of control) concentrations. 
 
 
Figure 34: Staurosporine treated primary rat hepatocytes, ATP and LDH levels after 2, 
6 and 24 hours incubation (Experiment 20091111). Results are shown as % of control 
±SD, control being 100%.    
 
Toxicity of rotenone was seen after 2 hours incubation both in ATP and LDH starting 
from 0.3125µM dose (ATP: 71% of control, LDH 108% of control) and increased (with 
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LDH) or reduced (with ATP) with higher doses, 0,625µM, 0,125µM, 1,25µM and 
2.5µM (Figure 35; ATP: 57, 27, 11 and 3% of control, LDH 108, 110, 165 and 225% of 
control). Results were the same with longer incubation times (seen in figure 35). From 
the three drug compounds tested rotenone showed the most clear toxicity effects in each 
timepoint. 
 
 
Figure 35: Rotenone treated primary rat hepatocytes, ATP and LDH levels after 2, 6 or 
24 hours incubation. Results are shown as % of control ±SD, control being 100%.    
 
The effect  on ATP and LDH levels was seen with 12.5µM concentration of tolcapone 
and increased after it with 25µM (ATP 33% of control; LDH 123% of control) and 
50µM (ATP 2% of control; LDH 165% of control) doses at 2h timepoint as seen in 
figure 36. After 6 hours and 24 hours incubation tolcapone showed the same kind of 
dose-response effects: The decrease in ATP levels as well as the increase in LDH levels 
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were seen the starting from 12.5µM dose: the smaller doses did not show remarkable 
cytotoxicity. 
 
 
Figure 36: Tolcapone treated primary rat hepatocytes, ATP and LDH levels after 2, 6 
or 24 hours incubation. Results are shown as % of control ±SD, control being 100%.    
 
 
10.5 Evaluation of phototoxicity 
 
To evaluate phototoxicity in live cell method the untreated primary rat hepatocytes were 
stained with Hoechst 33342 and TMRM, with 4 different concentrations of Hoechst 
33342 µM/TMRM nM: 0.2/5, 0.4/10, 0.8/20 and 1.6/40 and control without dyes. Three 
concurrent wells were done for each concentration. In one plate two concurrent “sets” of 
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concentrations existed: The left side of the plate was exposured using Cellomics 
Arrayscan  and  the  right  side  of  the  plate  was  not.  Exposure  times  were  as  follows:  
Channel 1 (Hoechst 33342) 0.1 seconds, Channel 2 (TMRM) 0.8 seconds. After 
exposing ATP and LDH levels were measured from each well and values of exposed 
wells  were  compared  to  non-exposed  ones.  The  experiment  was  done  twice.  No  
phototoxicity was seen, the results are shown in figure 37. 
 
 
Figure 37: Phototoxicity testing. Cells were untreated primary rat hepatocytes, probes 
used were Hoechst 33342 and TMRM, with 4 different concentrations (Hoechst 33342 
µM/TMRM nM): 0.2/5, 0.4/10, 0.8/20 and 1.6/40 and control without dyes. Three 
concurrent wells were done for each concentration. The left side of the plate was 
exposured using Cellomics ArrayScan and the right side of the plate was not. Exposure 
times were as followings: Channel 1 (Hoechst 33342) 0.1 seconds, Channel 2 (TMRM) 
0.8 seconds. After exposuring ATP and LDH levels were measured from each well and 
values of exposed wells were compared to non-exposed ones. In figure results are 
shown as % of control ±SD, control being 100%. 
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11. DISCUSSION 
 
The aim of this study was to set up and optimize new high content screening- methods 
for early drug toxicity testing. HCS instrument is basically a user-friendly automated 
fluorescence microscope situated in a box and equipped with image analysis software. 
In the study two protocols were set up and optimized to examine mitochondrial damage 
caused by different mitochondria toxic compounds. Both live cells (mitochondria probe 
TMRM) and fixed cells (cytochrome c antibody together with Alexa 488 conjugated 
secondary antibody) were used. The sensitivity and the results as dose responses of 
these methods were compared to each other and to conventional analyse of cytotoxicity 
(ATP  and  LDH  measurement).  In  addition,  two  different  cell  types,  primary  rat  
hepatocytes and Hep G2 cells were used and compared. Staurosporine, rotenone and 
tolcapone  were  chosen  as  test  compounds  because  they  are  known  to  be  hepatotoxic,  
and they all are known to have an effect for mitochondria and its function. 
 
After optimizing the subculturing procedure for HepG2 cells both live cell method and 
fixed cell method were optimized to find the optimal probe concentrations, overall 
experimental conditions and input parameters for both methods and cell types used. 
Both cell types showed a response for drug treatments. However, rat primary 
hepatocytes were selected to be used since they showed more response for drug 
treatments and the results were more reproducible. This was seen both visually and in 
numeric results (output parameters). The cytotoxic effects of the test compounds were 
seen earlier and with lower drug concentrations. In addition, tolcapone showed only 
very slight toxicity with HepG2-cells whereas primary hepatocytes showed much more 
effect. The difference between cell models is due to the better metabolism capacity with 
primary rat hepatocytes. 
 
Hoechst 33342 and TMRM probes were used in the live cell method. In damaged cells 
apoptosis causes the condensation and fragmentation of the nucleus and when nuclei are 
stained with Hoechst 33342 the apoptotic effect is seen when the area of the nucleus is 
smaller and the intensity of the fluorescence is increased. In mitochondria toxic 
compounds can reduce membrane potential through several mechanisms, for example 
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uncoupling and complex I inhibition. When using TMRM probe both the area and the 
intensity of the fluorescence are decreased. The probes used in live cell method worked 
well together since their excitation/emission spectras separated so that the signal 
identification was possible to do using Cellomics ArrayScan, as well as the incubation 
times that were possible to combine. The concentrations of the probes and the exposure 
times was tried to keep as low as possible in order not to cause phototoxicity to the 
cells. No phototoxicity was detected with concentrations used. At the same time the 
quality  of  the  image  and  the  identification  of  the  cells  were  tried  to  get  as  good  as  
possible. The most sensitive output parameters measured in the live cell method were 
nucleus intensity and average intensity of mitochondria area. 
 
With fixed cell method the purpose was to measure Cytochrome C release from 
mitochondria  as  a  response  to  cytotoxic  compounds.  The  aim  was  to  stain  the  
mitochondria of the cells with Mitotracker Red CMXRos and Cytochrome C using 
cytochrome c antibody and Alexa 488-conjugated secondary antibody to see the 
colocalization of these signals. However, with the experimental conditions used, the 
Mitotracker Red CMXRos probe was leaking from the mitochondria during fixation 
procedure and therefore could not be used in these studies. Other probes, the nucleus 
probe Hoechst 33342, and cytochrome c antibody together with Alexa 488 conjugated 
secondary antibody worked out well.  
 
After  the  methods  were  optimized  they  were  tested  and  the  results  were  compared  to  
each other and to conventional analysis of cytotoxicity, ATP and LDH measurement. 
As  mentioned  before,  the  primary  aim  with  fixed  cells  (to  do  the  colocalization  with  
cytochrome c and mitochondria) did not work out and only the leakage of the 
cytochrome c to nucleus area was measured. With live cells the membrane potential of 
mitochondria was measured using TMRM. Membrane potential correlates to the 
intensity of the probe fluorescence, examples are seen in figure 17 (figure from 
cellomics) and 20. All three examined drugs showed response in experiments which 
was seen as reduced intensity of fluorescence of TMRM in mitochondria in drug treated 
cells, the highest concentrations affecting the most. With fixed cells the dose response 
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was not that clearly seen and for this reason among the others (discussed in more detail 
below) live cell method was the one used in experiments.  
 
The live cell method was more sensitive and reliable than fixed cell method: this was 
seen in every experiment (three concurrent were done) both visually and numerically 
(output parameters). Live cell method showed smaller sd:s and the results were more 
similar between experiments. Also the probe leaking with fixed cell method (the 
inadequate optimization of fixation protocol) affected negatively to the results of fixed 
cell method. In addition, the handling of the cells was easier with live cell method. Live 
cell method was faster to perform because there were no immunocytochemistry part that 
had to be done as was with fixed cell method: this made live cell method also the 
cheaper one when there were no expensive antibodies that were used. The costs that 
immunocytochemistry protocol caused by increasing the working hours must also take 
into account. However, the advantages of the fixed cell method are that with multiple 
plates in a screen a robotic arm could be used and that the plates can be scanned again 
and even stained with another probe again. Also when screening multiple plates the use 
of the live cells is more challenging and requires automated pipetting and an incubator 
connected to the Cellomics ArrayScan instrument, since the steps must be graded so 
that the scans etc. do not overlap.  
 
Of the three timepoints 2h timepoint was the best one used, it was most sensitive and 
dose responses were most clear: after 24h incubation cells were usually dead which 
affected  negatively  to  the  results.  6h  timepoint  was  also  good,  but  the  timepoint  itself  
caused that the working hours at the laboratory growed significantly over 8h (this was 
the supposed working hours per day at the laboratory). In addition, after 6h and 24h 
incubation cells may have fixed the smallest injuries caused by test compounds.  
 
The test compound that showed most reproducible results and worked best both with 
live cell and fixed cell method as well as showed clear nuclear and mitochondrial 
cytotoxic effects was rotenone. Rotenone showed toxicity already after 2h incubation 
and made this in every experiment: also the sd:s with rotenone were the smallest ones 
when comparing to staurosporine and tolcapone. Staurosporine showed most toxicity in 
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each assay, but the reproducibility of the staurosporine results was poor since the cells 
were dead particularly after 24h incubation. In this situation the measuring of the 
mitochondrial or nuclear intensity was challenging, not only for the optimization of the 
input parameters but also due to the over-exposure and the detachment of the dead cells 
from  the  bottom  of  the  well.  Tolcapone  did  not  show  that  much  toxicity  than  
staurosporine and rotenone even after 24h incubation, and according to these 
observations it was the least toxic drug of the three model substances used to the 
hepatocytes. For these reasons, rotenone would serve best as a positive control in the 
screening assays.  
 
One  of  the  biggest  problems  in  using  Cellomics  ArrayScan  was  that  the  toxic  effects  
were seen by eye, but it was very difficult to set the input parameters so that the same 
would have been seen as numeric results. This is most likely caused by poor 
identification of the objects and therefore the input parameters must be optimized more.  
 
To improve the sensitivity of the experiments one additional option that could be done 
is to determine if the cell is dying either apoptotic or necrotic way. A bioapplication 
which measures spots in nucleus area could be used and the cells would be scanned with 
20x or 40x objective so that the spots are visible in nucleus. This is because only 
apoptotic cell death causes fragmentation of the DNA in nucleus. In necrotic cell death 
DNA is just falling apart and in necrotic nucleus DNA spots are not seen. Anyway, this 
was not included in this thesis, but might be one possible improvement in method 
optimization. In addition, in further experiments it is useful to measure and combine 
more Cellomics ArrayScan output parameters: this could make the method more 
sensitive and improve the assay results. Also ways to measure easily possible compound 
precipitation and to detect if the cells are still alive would be needed for a reliable assay. 
In these assays the brightfield images were used to determine the condition of the cells 
and to see if they are still alive: this is not possible to do with single fluorescent probe. 
Measuring of the fluorescence is not reasonable if the cells are not even alive and dead 
cells cause errors to the results.  
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For screening purposes it would be useful to have a clear threshold value for toxicity so 
that the comparison of the results would be as easy as it is with conventional 
cytotoxicity measuring methods using EC50-value (Effective Concentration: this refers 
to the concentration of a drug or antibody that causes the effect that is in a halfway 
between the baseline and maximum after certain exposure time). However,  measuring  
EC50- value  is difficult with Cellomics ArrayScan where the dose responses are not 
always very clear  due to microscopical examination where the measured difference 
between minimum and maximum concentration can be small and the sd:s are big. In 
addition, the difference in the HCS and conventional cytotoxicity analysis methods 
must be taken into account: when Cellomics ArrayScan measures the certain amount of 
fields in each well, the conventional analysis of cytotoxicity measure the effect in whole 
well  and  in  whole  cell  population.  To  do  the  same  measurement  with  Cellomics  
ArrayScan all the fields should have been scanned, which is not reasonable, since it 
would take too much time to scan all the fields. The main point in HCS is to reduce time 
needed in experiments and to find more sensitive ways to measure toxicity. However, 
further method development would be needed to find a valid threshold value for 
Cellomics ArrayScan assays. 
 
 
12. CONCLUSIONS 
 
In  this  Pro  Gradu  the  aim  of  the  study  was  to  implement  and  optimize  new  HCS-
methods for researching mitochondrial toxicity. After optimizing cell culture conditions 
for the hepatoma cell line HepG2s, the optimizations of live cell and fixed cell methods 
were done for both cell models used, the HepG2s and primary rat hepatocytes. The 
probe concentrations used as well as the test compound concentrations were optimized. 
Also all the Cellomics ArrayScan parameters were defined. The most sensitive 
parameters expressing the toxicity were selected and compared to see the possible 
difference between new methods and the conventional cytotoxicity analysis method, 
meaning the measure of ATP and LDH. 
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As a conclusion, conventional analysis of cytotoxicity show clearer dose responses and 
are as sensitive to cytotoxic effects as HCS methods so far. More optimization and 
method improvement must be done to get the methods work; this was not possible in 
this thesis due to time limits. Attention must be paid to the probes used, to see if better 
probe combinations work better together and optimize fixation protocol to get the 
mitochondrial probes work also with fixed protocols: with live cell method there were 
no problem. The problem with probe leakage from channel to channel would be needed 
to solve, to see if the problem is in method used or in Cellomics ArrayScan itself. 
Especially the input parameters require more optimization to get the object 
identification adequate.  When comparing the methods with each other the live cell 
method was more sensitive in predicting toxicity than the fixed cell method. Maybe this 
was because of the problems that were confronted with the fixed cell method. Also the 
variations in the results of the fixed cell method were bigger than variations in the live 
cell method and the dose-response were not that good as with live cells. On the other 
hand, as told before, it is much easier to work with fixed cells when there is no need to 
take that much care to the conditions cells are kept. Also the robot hand helped working 
with fixed cells.  
 
Of the three test compounds used staurosporine was the most toxic to the cells 
according to test  results.  Toxicity was clearly seen already after 2h incubation and the 
cells were all dead after 24h incubation. However, rotenone, that was not that toxic to 
the hepatocytes but more toxic than tolcapone, was the most reliable drug to show 
toxicity: it effects were reproducible and the dose-responses were clear. Tolcapone was 
the least toxic and no clear toxic effects were seen with tolcapone after 2h incubation: 
after 24h incubation some effects were detectable.  
 
The major challenge with HCS is the variation of the results which, however, is typical 
in  microscopical  examination.  On  the  whole  Cellomics  ArrayScan  is  a  useful  and  
powerful device in toxicity screening. Possibility for multiplexing and combining 
different parameters makes HCS methods sensitive when many different cellular 
functions can be measured simultaneously. This spares money, time and resources. In 
addition, the mechanisms that cause toxicity are possible to specify with HCA. There 
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are lots of different bioapplications available and many helpful tools (reference wells 
etc) in Cellomics ArrayScan which makes it a powerful tool for early stage toxicity 
screening. 
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